EurekaMag
+ Translate
+ Most Popular
Investigations on the organic drift in North Swedish streams
Limitations of Using Microsoft Excel Version 2016 (MS Excel 2016) for Statistical Analysis for Medical Research
Phloem necrosis of coffee in Surinam
Anatomy of Mystus seenghala IV Nervous system
Integrated farming system for gardenland conditions of Coimbatore district - an over view
Tetrapleure (Tetrapleura tetraptera), an unknown African medicinal and spice plant
The origin and phylogenetic significance of the trochophoran larvae 2. evolutionary significance of the larvae of coelomate worms and mollusks
Comparison of rice bran and maize bran as feeds for growing and fattening pigs
Enterobacter amnigenus. An unusual human pathogen
Influence of Seriboost foliar application on leaf yield and leaf protein content in mulberry (Morus spp.), in relation to silkworm cocoon production
The identity of the lipstick mold of cultivated mushrooms agaricus bisporus
Advantages and disadvantages of bordeaux mixture and of lime-sulphur used on apples in the growing season
'Pan-sukh' disease of Rice in the Central Provinces
Geological age of the Ptilophyllum flora; a critical reassessment
Study of vitellogenesis in birds; physiological phases & role of folliculin in vitellogenesis
Evaluation of WCT coconut and Komadan coconut
Therapy for acne with saccharomyces boulardii
Evidence for Late Cretaceous N-S dextral shear in the west-central crystalline core, North Cascades, Washington
'Rajeshwari' - a high-yielding white seeded variety of sesame for Andhra Pradesh
Manufacture of Ricotta cheese from whey fortified with skim milk powder using different acidulants
Occurrence of Eutrichophilus mexicanus (Rudow, 1866) and Eutrichophilus lobatus (Ewing, 1936) (Phthiraptera: Trichodectidae) on Sphiggurus villosus (Cuvier, 1825) (Rodentia: Erethizontidae) in Rio de
Factors affecting fruitfulness in durian (Durio zibethinus Murr.). I. Flowering and pollination
Bronchial cuff pressure change caused by left-sided double-lumen endobronchial tube displacement
Some Biological Applications of Organometallic Compounds
The composition of pampas-grass (Cortaderia argentea.)

List of PDF Full Texts available from EurekaMag Chapter 69885

Chapter 69885 contains a list of PDF Full Texts available from EurekaMag.




Impact of the EML4-ALK variant on the efficacy of alectinib (ALC) in untreated ALK+ advanced NSCLC (aNSCLC) in the global phase III ALEX study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii494-viii495 (2018)

Efficacy of lorlatinib in patients (pts) with ROS1-positive advanced non-small cell lung cancer (NSCLC) and ROS1 kinase domain mutations
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii495 (2018)

Gefitinib with or without pemetrexed in nonsquamous (NS) non-small cell lung cancer (NSCLC) with EGFR mutation (mut): Final overall survival (OS) results from a randomized phase II study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii495-viii496 (2018)

Phase III study of gefitinib (G) versus gefitinib+carboplatin+pemetrexed (GCP) as first-line treatment for patients (pts) with advanced non-small cell lung cancer (NSCLC) with EGFR mutations (NEJ009)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii496 (2018)

An open-label, multicenter, phase I study of ABBV-399 (telisotuzumab vedotin, teliso-V) as monotherapy (T) and in combination with erlotinib (T+E) in non-small cell lung cancer (NSCLC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii496-viii497 (2018)

Pembrolizumab in performance status 2 patients with non-small cell lung cancer (NSCLC): Results of the PePS2 trial
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii497 (2018)

A randomised phase III trial evaluating the addition of denosumab to standard first-line treatment in advanced NSCLC: The ETOP and EORTC SPLENDOUR trial
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii498 (2018)

IMpower150: Clinical safety, tolerability and immune-related adverse events in a phase III study of atezolizumab (atezo) + chemotherapy (chemo) ± bevacizumab (bev) vs chemo + bev in 1L nonsquamous NSCLC
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii498-viii499 (2018)

Randomized, double-blind, placebo (P)-controlled phase III non-inferiority study of darbepoetin alfa (D) for anemia in patients (pts) with advanced NSCLC: An ad hoc subgroup analysis of pts with baseline hemoglobin (Hb) ≤10.0g/dL
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii499-viii500 (2018)

ODM-207: A novel BET bromodomain inhibitor with antitumor activity in nonclinical models of ER+ breast cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii5 (2018)

HER2-positive breast cancer resistance to trastuzumab is associated with metabolic switch
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii5 (2018)

Combination treatment with the PARP inhibitor niraparib and chemotherapeutics in a preclinical model of KRAS/BRAF mutated colorectal cancer cell lines across the four consensus molecular subtypes
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii5 (2018)

Assessment of cfDNA in patients with metastatic colorectal cancer treated with cetuximab monotherapy
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii50 (2018)

Quantifying circulating cell-free DNA as clinical biomarker
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii50 (2018)

Gene expression profile (GEP) and survival among patients with advanced ovarian cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii50 (2018)

Impact of early steroids use on clinical outcomes of patients with advanced NSCLC treated with immune checkpoint inhibitors
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii500 (2018)

Dose modification and therapy interruption due to adverse events in treatment with anlotinib for refractory advanced NSCLC: Data from ALTER0303
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii500-viii501 (2018)

Incidence of cardiac toxicities in patients with advanced non-small cell lung cancer treated with osimertinib: A combined analysis of two phase III randomized controlled trials
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii500 (2018)

Immune-related adverse events (irAEs) and survival (OS) in metastatic non-small cell lung cancer (mNSCLC) patients (pts) treated with immunotherapy
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii501 (2018)

Dose-determination results from a phase Ib/II study of ceritinib (CER) + ribociclib (RIB) in ALK-positive (ALK+) non-small cell lung cancer (NSCLC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii501-viii502 (2018)

Lung cancers carrying distinct ALK fusion variants demonstrate similar responsiveness to ALK tyrosine kinase inhibitors
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii502 (2018)

A multicenter study of mutational profiling of Chinese ALK+ non-small cell lung cancer patients with acquired resistance to crizotinib using next generation sequencing
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii502 (2018)

Safety profile and effectiveness of alectinib in the real-world surveillance study of 1251 Japanese patients with ALK-positive non-small cell lung cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii502 (2018)

Efficacy and safety of crizotinib in previously treated patients (Pts) with ALK+ advanced non-small cell lung cancer (NSCLC) aged ≥65 years (y)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii503 (2018)

Long-term safety of crizotinib in previously treated patients (pts) with ALK-positive advanced/metastatic non-small cell lung cancer (NSCLC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii503-viii504 (2018)

Impact of lorlatinib on patient-reported outcomes (PROs) in patients (Pts) with advanced ALK+ or ROS1+ non-small cell lung cancer (NSCLC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii504-viii505 (2018)

Real-world progression-free survival of patients on anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitors (TKIs) for ALK+ non-small cell lung cancer (NSCLC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii504 (2018)

Docetaxel plus ramucirumab with primary prophylactic pegylated-granulocyte-colony stimulating factor for pretreated non-small cell lung cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii505 (2018)

The efficacy and safety of crizotinib in patients with ROS1 positive advanced stage NSCLC: The real-world experience from Turkey
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii505 (2018)

Open-label multicenter randomized phase II study of docetaxel plus bevacizumab or pemetrexed plus bevacizumab for elderly (≥75 years old) patients (pts) with previously untreated advanced non-squamous non-small cell lung cancer (NSCLC): TORG1323
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii506 (2018)

Safety of nintedanib plus docetaxel in advanced non-squamous NSCLC (nsNSCLC) patients: The preliminary results of the SENECA (second-line nintedanib in non-small cell lung cancer) trial
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii506-viii507 (2018)

Circulating tumor DNA (ctDNA) in advanced non-small cell lung cancer (NSCLC) from HIV-infected patients is associated to shorter overall survival (OS): Results from phase II trial (IFCT-1001 CHIVA)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii507 (2018)

Final results of the concordance analysis of PD-L1 immunohistochemistry (IHC) assays and polymerase chain reaction (PCR) in non-small lung cancer (NSCLC) patients
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii507 (2018)

Derived neutrophil-to lymphocyte ratio (dNLR) change between baseline and cycle 2 is correlated with benefit during immune checkpoint inhibitors (ICI) in advanced non-small cell lung cancer (NSCLC) patients
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii508 (2018)

Prognostic factors in non-small cell lung cancer (NSCLC) patients (pts) with brain metastases (BM) treated with immune checkpoint inhibitors (ICI)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii508-viii509 (2018)

Association of efficacy and immune-related adverse events (irAEs) in patients with NSCLC receiving immune-checkpoint inhibitors (ICIs)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii509 (2018)

Identification of genomic markers of sensitivity and resistance to checkpoint inhibitors in non-small cell lung cancer in a real world clinico-genomic database
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii509-viii510 (2018)

Tumor mutation burden (TMB) estimation using small-sized targeted next-generation sequencing (NGS) to predict efficacy of immune checkpoint inhibitors (ICIs) for non-small cell lung cancer (NSCLC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii509 (2018)

Circulating tumor DNA and RNA as an exploratory biomarker to evaluate GT0918 in a phase I/II clinical trial in mCRPC patients
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii51-viii52 (2018)

Accurate measurement of tumor mutation burden in liquid biopsy (bTMB) using a 500 gene panel
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii51 (2018)

Predicting survival benefit of capecitabine plus cisplatin in patients with metastatic gastric cancer patients using quantitative proteomics
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii51 (2018)

Detection of microsatellite instability (MSI) with a novel set of 7 Idylla biomarkers on colorectal cancer samples in a multi-center study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii51 (2018)

Prediction of PD-1 immunotherapy (IO) response for KRAS mutated non-small cell lung cancer (NSCLC) based on co-mutations using a computational biological model
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii510-viii511 (2018)

Neutrophil-platelet score (NPS), a predictive systemic inflammation score for PD-1 immune checkpoint inhibitors (ICI) in pretreated advanced non-small cell lung cancer (NSCLC) patients
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii510 (2018)

HLA-DrbB1 heterozygosis and early auto-antibody rise predict prolonged survival in metastatic NSCLC patients undergoing PD-1 blockade
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii510 (2018)

Preliminary results of PRINCiPe (predictors of resistance to immunotherapy with nivolumab [NIV]) study in advanced pretreated non-small cell lung cancer (APNSCLC), investigating the role of an immune genomic signature (IGS) including JAK2, JAK3, PIAS4, PTPN2, STAT3, IFNAR2 alterations
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii511-viii512 (2018)

Association between early immune-related adverse events and clinical outcomes in patients with advanced non-small cell lung cancer treated with pembrolizumab as first-line therapy: A retrospective multicenter cohort study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii511 (2018)

Immunosenescence (iSenescence) correlates with disease progression in advanced non-small cell lung cancer (aNSCLC) patients treated with PD-(L)1 inhibitors (IO)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii511 (2018)

Basal lymphopenia as a potential predictor of benefit from immunotherapy in metastatic non-small cell lung cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii512 (2018)

Soluble immune biomarkers to anti-PD1 treatment in non-small cell lung cancer (NSCLC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii512-viii513 (2018)

The need of re-biopsy: Increase in PD-L1 expression from initial stage to recurrence of non-small cell lung cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii512 (2018)

Evolution and clinical impact of EGFR mutations in circulating free DNA in the BELIEF trial
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii513 (2018)

Pre-treatment EGFR-T790M subclones in lung adenocarcinoma harboring activating mutation of EGFR: A positive prognostic factor for survival?
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii513-viii514 (2018)

Clinical characterization of rare EGFR mutations in non-small cell lung cancer and in silico prediction of drug sensitivity
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii513 (2018)

ABCB1 genetic polymorphism and pharmacokinetic analysis of low dose erlotinib in frail patients with EGFR mutation (mt)-positive, non-small cell lung cancer: TORG1425
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii514 (2018)

The plasma ctDNA monitoring during epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) treatment in patients with EGFR mutant non-small cell lung cancer (JP-CLEAR trial)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii514 (2018)

Applicability of lung-molGPA index in non-small cell lung cancer patients with various gene alterations and brain metastases
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii515 (2018)

Testing for and frequency of molecular alterations in patients with advanced NSCLC in Germany. Results from the prospective German registry CRISP (AIO-TRK-0315)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii515 (2018)

Longitudinal plasma monitoring of subjects treated with EGFR-TKIs allows better understanding of evolution of acquired resistance and can inform optimal treatment strategies
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii515 (2018)

TP53 mutations impair overall survival of TKI-treated patients with oncogene-driven NSCLC
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii516-viii517 (2018)

Molecular landscape of osimertinib resistance revealed by targeted panel sequencing and patient-derived cancer models in non-small cell lung cancer patients
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii516 (2018)

Cell-free circulating tumour DNA (ctDNA) in the management of patients with non-biopsiable advanced non-small cell lung cancer (NSCLC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii516 (2018)

Prognostic value of the neutrophil-to-lymphocyte ratio (NLR) in advanced non-small cell lung cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii517 (2018)

Hybrid capture NGS reliably detects a spectrum of clinically significant genetic aberrations in both, primary diagnostics and the relapse scenario
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii517 (2018)

A phase II study of nedaplatin and nab-paclitaxel for patients with previously untreated advanced squamous cell lung cancer (KRSG1302)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii517 (2018)

Randomized phase II study comparing cisplatin + pemetrexed + bevacizumab with carboplatin + paclitaxel + bevacizumab in treatment-naïve advanced non-squamous non-small cell lung cancer (CLEAR study)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii518 (2018)

Bevacizumab as first-line treatment in advanced non-squamous non-small cell lung cancer (NSCLC) in patients aged over 65 years in France: Final results of the AVANTAGE study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii518 (2018)

A multicenter single-arm phase II study of nab-paclitaxel/carboplatin for non-small cell lung cancer patients with interstitial lung disease
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii519-viii520 (2018)

Phase I dose expansion data for M6620 (formerly VX-970), a first-in-class ATR inhibitor, combined with gemcitabine (Gem) in patients (pts) with advanced non-small cell lung cancer (NSCLC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii519 (2018)

The frequency of primary cilia, CD8+ tumor infiltrating lymphocytes and PD-1 expression in renal cell carcinoma of clear-cell type
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii52 (2018)

Somatic and germline mutations of Chinese gastric cancer patients
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii52-viii53 (2018)

Association of MMR protein expression and MMR gene mutations in Chinese colorectal cancer patients
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii52 (2018)

HALO 107-201: A phase Ib, open-label, multicenter study of pegvorhyaluronidase alfa (PEGPH20) + docetaxel in patients (pts) with recurrent locally advanced or metastatic non-small cell lung cancer (NSCLC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii520 (2018)

Randomised phase II trial of oral vinorelbine (OV) and cisplatin (P) followed by maintenance with OV versus gemcitabine (GEM) and P followed by maintenance with GEM as first-line chemotherapy in advanced non-small cell lung cancer (NSCLC) patients (pts) with squamous (sq) histological type
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii520-viii521 (2018)

Phase III study comparing bevacizumab plus erlotinib (BE) to erlotinib (E) in patients (pts) with untreated NSCLC harboring EGFR mutations: NEJ026
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii521 (2018)

Afatinib versus erlotinib as second-line treatment of patients (pts) with advanced lung squamous cell carcinoma (SCC): Final analysis of the global phase III LUX-Lung 8 (LL8) trial
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii521 (2018)

Real world data of osimertinib in patients with central nervous system (CNS) metastasis in ASTRIS Korean subset
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii522 (2018)

A randomized phase II trial of erlotinib or erlotinib and bevacizumab in patients with advanced EGFR mutant non-small cell lung cancer (NSCLC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii522 (2018)

A phase II study of first-line afatinib for patients aged 75 or older with EGFR mutation-positive advanced non-small cell lung cancer: North East Japan study group trial NEJ027
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii522-viii523 (2018)

Management of leptomeningeal metastases in EGFR mutated non-small cell lung cancer: Analysis of tyrosine kinase inhibitors sequence
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii523 (2018)

Risk of not receiving second-line therapy is high in EGFR mt+ pts: Real world data of certified lung cancer centers on treatment sequence in EGFR mt+ pts
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii523 (2018)

Patterns of recurrence to Osimertinib in T790m positive NSCLC: A Swiss cohort study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii523-viii524 (2018)

Efficacy of afatinib in the clinical practice: First results of the GIDEON trial: A prospective non-interventional study (NIS) in EGFR mutated NSCLC in Germany
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii524 (2018)

Osimertinib treatment for patients with EGFR exon 20 insertion positive non-small cell lung cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii524-viii525 (2018)

The characteristics and clinical outcome of metastatic NSCLC harboring uncommon EGFR mutation at Thailand's tertiary referral center
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii525 (2018)

Combination of the S49076 with gefitinib in NSCLC patients progressing on EGFR-TKI and harboring MET/AXL dysregulation
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii525 (2018)

Afatinib dose intensity and clinical efficacy in advanced EGFR-mutated non-small cell lung cancer: UK multicentre real-life data
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii526 (2018)

Comparative analysis of overall survival using propensity score between first- and second-generation EGFR-TKI: Real world data of 1354 patients with EGFR mutant NSCLC
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii526-viii527 (2018)

EGFR tyrosine kinase inhibitors in non-small cell lung cancer: Nationwide register-based cohort study in Sweden
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii526 (2018)

Phase IV, open-label, multicentre trial of afatinib in patients (pts) aged ≥70 yrs with NSCLC harbouring common (Del19/L858R) EGFR mutations: Preliminary results
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii527 (2018)

Is there a difference in PFS or OS of T790M-mutated NSCLC patients treated with osimertinib either after chemotherapy or immediately after previous target therapy?
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii527 (2018)

Bone metastasis reduces responsiveness to EGFR-TKIs in patients with EGFR-mutated advanced lung adenocarcinoma
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii527 (2018)

Which of afatinib and gefitinib/erlotinib is the better EGFR-TKI to be followed by osimertinib?
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii527-viii528 (2018)

Biopsy on progression in EGFR mutation positive (EGFRm) advanced non-small cell lung cancer (aNSCLC) patients (pts): A Canadian experience
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii528 (2018)

ASTRIS: A real world treatment study of osimertinib in patients (pts) with EGFR T790M-positive non-small cell lung cancer (NSCLC) - European subset
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii528 (2018)

Updated results of M7824 (MSB0011359C): A bifunctional fusion protein targeting TGF-β and PD-L1, in second-line (2L) NSCLC
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii529 (2018)

Impact of blood-based biomarkers on survival outcomes with pembrolizumab in pre-treated advanced non-small cell lung cancer (NSCLC) patients (pts)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii529 (2018)

KEYNOTE-189 study of pembrolizumab (pembro) plus pemetrexed (pem) and platinum vs placebo plus pem and platinum for untreated, metastatic, nonsquamous NSCLC: Does choice of platinum affect outcomes?
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii529-viii530 (2018)

Selective induction of PD-L1 expression in plasma-derived exosomes by gemcitabine-nab-paclitaxel vs. FOLFIRINOX in pancreas cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii53 (2018)

Validation of the Mamma Typer® pathological complete response (pCR)-score as a predictor for response after neoadjuvant chemotherapy (NACT) in patients with early breast cancer (BC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii53 (2018)

Phase I dose escalation of pembrolizumab given concurrently with palliative thoracic radiotherapy (RT) for NSCLC
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii530 (2018)

Efficacy and safety of nivolumab for cytotoxic chemotherapy unfit patients with advanced non-small cell lung cancer: A phase II study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii531 (2018)

Effects of antibiotic use during immunotherapy in metastatic non-small cell lung cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii531 (2018)

GECP 1605/NIVEX TRIAL nivolumab in the real world: The SPANISH expanded access program experience in pretreated advanced NSCLC
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii531 (2018)

EVIDENS: An observational study of nivolumab-treated patients in advanced non-small cell lung cancer (NSCLC) in a real-world setting: Initial results on 1394 patients
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii532 (2018)

Fractional polynomial network meta-analysis: A different approach to indirectly assess the comparative efficacy of 2L+ cancer immunotherapy (CIT) treatments for metastatic NSCLC
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii532-viii533 (2018)

Prior or concurrent radiotherapy and nivolumab immunotherapy in non-small cell lung cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii533 (2018)

Immunotherapy in elderly patients (≥ 75 yrs) with advanced non-small cell lung cancer (NSCLC): A multicenter Italian experience
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii533 (2018)

Immune checkpoint inhibitor efficacy and safety in elderly non-small cell lung cancer patients
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii533-viii534 (2018)

Radiological identification of rapid progressions in advanced NSCLC patients treated with nivolumab
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii534 (2018)

Nivolumab in non-small cell lung cancer: French evaluation of use, current practices and medico-economic approach
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii534 (2018)

Role of immunotherapy (I) for advanced, pre-treated, non-squamous NSCLC (APNS-NSCLC): Preliminary data of a pooled analysis with network meta-analysis
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii534-viii535 (2018)

Evaluation of progression-free survival (PFS) and one-year (1y) survival as surrogate endpoints (SE) in previously treated advanced non-small cell lung cancer (adNSCLC) in the era of immuno-oncology (IO)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii535 (2018)

Efficacy of second-line nivolumab after early time to progression on first-line cytotoxic chemotherapy in patients with advanced non-small cell lung cancer (NSCLC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii535 (2018)

First analysis of patients (p) with stage IV non-small cell lung cancer (NSCLC) of the thoracic tumor registry (RTT) of the Spanish Lung Cancer Group (SLCG)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii535-viii536 (2018)

Extra-cost of brain metastases in patients with non-squamous non-small cell lung cancer (NSCLC): A French national hospital database analysis
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii536 (2018)

Localablative treatment for synchronous oligometastatic lung cancer: A propensity score analysis of 180 patients
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii536 (2018)

Treatment patterns in patients (pts) with stage IIIB-IV non-small cell lung cancer (NSCLC) in Sweden: The SCAN-LEAF study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii537 (2018)

NSCLC with well controlled extra-cranial disease but uncontrolled brain metastases
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii537-viii538 (2018)

Risk assessment in brain-only oligometastatic non-small cell lung cancer (BOO-NSCLC) patients (pts): Recursive partioning analysis (RPA) model modification
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii538 (2018)

LURET: Final survival results of the phase II trial of vandetanib in patients with advanced RET-rearranged non-small cell lung cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii538 (2018)

Vemurafenib in patients (pts) harboring BRAF V600 mutation: Results of non-small cell lung cancer (NSCLC) cohort from the AcSé trial
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii538-viii539 (2018)

Treatment patterns and overall survival in patients with BRAF-mutated metastatic non-small cell lung cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii539 (2018)

A prospective observational study of HER2 alterations in NSCLCs: HOT1303-A
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii539-viii540 (2018)

Tumor mutation burden assessment on FFPE samples using a targeted next-generation sequencing assay
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii54-viii55 (2018)

Cancer stem cell markers in pancreatic ductal adenocarcinoma
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii54 (2018)

MET exon 14 splicing mutation and its correlation with clinocopathological features in subjects with non-small cell lung cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii54 (2018)

Ecological diversity indices as measurements of tumor heterogeneity correlates with clinical outcomes in late stage small cell lung cancer (SCLC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii54 (2018)

A phase II study of trastuzumab monotherapy in pretreated patients with non-small cell lung cancers (NSCLCs) harboring HER2 alterations: HOT1303-B trial
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii540 (2018)

BPI-9016M, a novel c-Met inhibitor, in pretreated advanced solid tumor: Results from a first-in-human, phase I, dose-escalation study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii540 (2018)

Intracranial activity of ensartinib in patients with anaplastic lymphoma kinase positive (ALK+) non-small cell lung cancer (NSCLC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii541-viii542 (2018)

Clinical characteristics and outcomes of non-small cell lung cancer (NSCLC) patients harboring MET exon 14 splice sites mutations
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii541 (2018)

Risk of lung cancer following pulmonary tuberculosis: A nationwide population-based cohort study, South Korea
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii541 (2018)

Analysis of the relationship between heading N / L and survival in patients treated with immunotherapy in lung cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii541 (2018)

Optimal interval from preceding radiotherapy (RT) to enhance efficacy of immune check point inhibitors (ICIs): Consecutive analysis of 294 patients with non-small cell lung cancer (NSCLC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii542-viii543 (2018)

JNJ-61186372 (JNJ-372), an EGFR-cMET bispecific antibody, in advanced non-small cell lung cancer (NSCLC): An update on phase I results
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii542 (2018)

Tumor treating fields concurrent with standard of care for stage 4 non-small cell lung cancer (NSCLC) following platinum failure: Phase III LUNAR study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii543 (2018)

Afatinib (AFA) plus bevacizumab (BEV) combination after osimertinib (OSIME) failure for aDvanced EGFR-mutant non-small cell lung cancer (NSCLC): A multicenter prospective single arm phase II study (ABCD-study)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii543-viii544 (2018)

EXalt3: Phase III randomized study comparing ensartinib to crizotinib in anaplastic lymphoma kinase positive non-small cell lung cancer patients
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii543 (2018)

Fostering efficacy of anti-PD-1-treatment: Nivolumab plus radiotherapy in advanced non-small cell lung cancer: The FORCE trial
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii544 (2018)

Check Mate 592: A phase II exploratory study of biomarkers associated with the efficacy of first-line nivolumab (nivo) plus ipilimumab (ipi) in patients (pts) with stage IV or recurrent NSCLC
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii544-viii545 (2018)

Phase I study of the AXL inhibitor DS-1205c in combination with osimertinib in subjects with metastatic or unresectable EGFR-mutant NSCLC
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii545-viii546 (2018)

A phase III, randomized, open-label, multicenter study of SHR-1210 (anti-PD-1 antibody) in combination with pemetrexed and carboplatin as first line therapy in subjects with advanced/metastatic non-squamous non-small cell lung cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii545 (2018)

Nintedanib plus docetaxel in routine clinical practice: VARGADO, a German prospective non-interventional study (NIS) reflecting routine treatment conditions in an evolving NSCLC treatment landscape
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii545 (2018)

Ultra-early response capturing in the treatment of non-squamous NSCLC using diffusion-weighted MRI: A prospective multicenter study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii546 (2018)

Durvalumab in frail and elder patients with stage four NSCLC: The DURATION trial
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii546-viii547 (2018)

Randomized phase II trial of osimertinib with or without local consolidation therapy (LCT) for patients with EGFR-mutant metastatic NSCLC (NORTHSTAR)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii547 (2018)

The GATTO study: A phase I of the anti-EGFR tomuzotuximab (TO) in combination with the anti-MUC1 gatipotuzumab (GAT) in patients with EGFR positive solid tumors
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii547 (2018)

A prospective study examining cachexia predictors in patients with incurable cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii548-viii549 (2018)

Automated survival prediction in metastatic cancer patients using high-dimensional electronic medical record data
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii548 (2018)

Training oncologists and preparing patients for shared decision making about palliative systemic treatment: Results from the randomized controlled CHOICE study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii548 (2018)

Randomized clinical trial of an individualized intervention promotes cancer patients' prognostic awareness and reduces CPR received in the last month
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii549 (2018)

Timing of palliative care referral before and after a cluster randomized controlled trial (RCT) of early palliative care
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii549 (2018)

Effectiveness of a randomized control trial of an individualized, interactive advance care planning intervention in improving terminally ill cancer patients' psychological symptoms, quality of life and concordance between preferred and received life-sustaining treatments
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii549-viii550 (2018)

Microsatellite instability-high (MSI-H) colorectal cancers with elevated microsatellite alterations at selected tetranucleotide repeats (EMAST) signature represent a target population for immune checkpoint and DNA damaging therapies
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii55 (2018)

Levels of circulating fibroblast growth factor (FGF) 23 and prognosis of cancer patients with bone metastasis
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii55 (2018)

Clinical significance of RCAS1 and CD3 expression in non-small cell lung cancers in immunotherapy era
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii55 (2018)

Perspectives and attitudes towards the integration of oncology and palliative care in Japan: A nationwide survey
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii550-viii551 (2018)

Anticancer therapy at the end of life of breast, prostate, and colorectal cancer patients
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii550 (2018)

Access to palliative care before death in French cancer patients during the first two years after diagnosis: The national cancer cohort
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii550 (2018)

Current status of the integration of oncology and palliative care in Japan: A nationwide survey
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii550 (2018)

Cancer patients' perceptions of palliative care
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii551-viii552 (2018)

The impact of inclusion in home palliative program and distance to hospital on chemotherapy near end of life
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii551 (2018)

Evolving concurrent integration of oncology and palliative care at an ESMO designated center over a decade
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii551 (2018)

Multicenter feasibility study of physician orders for life-sustaining treatment (POLST) for terminal cancer patients
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii552 (2018)

The experience of onco-palliative care multidisciplinary meetings in Hotel Dieu de France University Hospital, an ESMO designated center of integrated oncology and palliative care
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii552 (2018)

Palliative care in advanced cancer: A clinical and ethical goal achieved?
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii552 (2018)

Understandability of the standard arabic translation of the EORTC QLQ-C15-PAL questionnaire by Egyptian patients with incurable cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii553-viii554 (2018)

Palliative chemotherapy for patient with advanced tumor and poor performance status: Are oncologists' hopes of benefit justified?
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii553 (2018)

End of life resource utilization among patients receiving immunotherapy for advanced cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii553 (2018)

Integration of oncology and palliative care
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii553 (2018)

How to practice oncology with a supportive and palliative care ambulatory unit: A French experience (HOASIS)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii554 (2018)

Prognostic impact of end-of-life chemotherapy in the last weeks for patients with advanced cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii554 (2018)

Medical-aid-in-dying use in the US Pacific Northwest
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii555-viii556 (2018)

Sarawak: Healthcare professionals' perception of palliative care at end of life
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii555 (2018)

Congruence between actual place of death and preferences of Egyptian patients with advanced cancer and their family caregivers
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii555 (2018)

Factors associated with length of stay in an acute palliative care unit: A retrospective analysis
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii555 (2018)

Brain metastases in Norway: A prospective cohort study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii556 (2018)

Post-traumatic growth and death anxiety in caregivers of cancer patients: PHOENIX study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii557 (2018)

Health-related quality of life in randomized controlled trials: A systematic review of prognostic significance
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii557 (2018)

Partners' perceptions of women's body image problems and satisfaction of breast reconstruction long-term after risk-reducing mastectomy
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii557-viii558 (2018)

Ostracism in adolescent cancer patients and predictors (OSTRACA Study): A study of the palliative care working committee of the Turkish Oncology Group (TOG)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii558 (2018)

The effect of music on the instant anxiety levels of oncologic patients receiving chemotherapy treatment
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii558 (2018)

Cognitive functions, coping strategies and psychological distress in patients with resected non-advanced cancer receiving chemotherapy: NEOcoping study data
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii558-viii559 (2018)

Cancer stigma related to beliefs of patients and care providers
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii559 (2018)

Relationship between depressive symptoms at social cognitive processing in partners of long term breast cancer survivors
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii559 (2018)

Comparative study of EGFR mutations detected in malignant pleural effusion, plasma and tumor tissue in patients with adenocarcinoma of the lung
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii56 (2018)

XmaI-RRBS DNA methylation screening resolves breast cancer epigenetic heterogeneity
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii56 (2018)

Prognostic value of change in neutrophil-lymphocyte ratio during treatment with first-line anti-PD1 therapy in metastatic melanoma
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii56 (2018)

A serum microRNA expression signature for radiosensitivity of non-small cell lung cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii56 (2018)

Making sense of self-conscious and emotion: Linking theory of mind and emotion in women with breast cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii560-viii561 (2018)

Pilot study of anxiety, depression, and quality of life in patients with the diagnosis of metastatic uveal melanoma
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii560 (2018)

Patients' and partners' views of treatment and care provided for metastatic castrate resistant prostate cancer (mCRPC) in the UK
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii560 (2018)

Exploring the effectiveness of crisis counselling and psycho-education in relation to improving mental wellbeing, quality of life and treatment compliance of breast cancer patients in Qatar
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii560 (2018)

Impact of cancer on the quality of life of Tunisian pediatric patients
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii561 (2018)

Perception, magnitude and implications of cancer related fatigue in breast cancer survivors: Study from a developing country
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii561 (2018)

Characteristics of the psychosomatic state of patients with lung cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii561 (2018)

Potential for value-based prescribing of oral oncology drugs
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii562 (2018)

Relation between center volumes for pancreatic and esophageal cancer surgeries and outcome in Belgium: A plea for centralization
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii562 (2018)

Worldwide comparison of colorectal cancer survival by topography and stage at diagnosis (CONCORD-2)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii562 (2018)

Variation in oncology drug approvals in Canada, the United States and Europe
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii563-viii564 (2018)

Magnitude of clinical benefit of cancer drugs approved based on single-arm trials (SAT) by the US Food and Drug Administration (FDA)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii564 (2018)

Magnitude of clinical benefit of trials supporting US Food and Drug Administration (FDA) approval of breakthrough and non-breakthrough drugs
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii564-viii565 (2018)

Public awareness of cancer in the Gaza-Strip: A cross-sectional study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii565-viii566 (2018)

Genetic testing of BRCA mutations in breast cancer in six European countries: Barriers and opportunities
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii565 (2018)

Cascade BRCA germline mutation (BGM) testing of women with breast (BC) or epithelial ovarian cancer (EOC) and their families with subsequent risk reducing surgery (RRS): A Canadian economics model
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii565 (2018)

Time to access to novel anticancer therapies in Slovenia in view of the ESMO-MCBS scores
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii565 (2018)

The impact of primary care access on mortality in lung cancer patients from Bronx, New York
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii566 (2018)

Breast cancer treatment waiting time, patient and provider contributions: An Egyptian breast cancer centre experience
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii566 (2018)

Are socioeconomic position and region of residence barriers for referral to phase I trials?
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii566 (2018)

Awareness and attitude towards breast cancer among Egyptian nurses at university affiliated hospitals: Tanta University Hospitals experience
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii567 (2018)

Working arrangements after cancer diagnosis: Who, what, when and how?
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii567-viii568 (2018)

Is age a barrier to chemotherapy? Rates of treatment in older patients with breast, colon or lung cancer in England in 2014: A national registry study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii567 (2018)

How advanced lung cancer patients are really treated at the population level? The Ontario, Canada experience
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii568 (2018)

Financial burden and financial toxicity in patients with colorectal, gastro-oesophageal, and pancreatobiliary cancers: A UK study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii568 (2018)

Influenza vaccine effectiveness among cancer patients: A population-based study using health administrative and laboratory testing data from Ontario, Canada
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii568 (2018)

Patient reported stressors in the practical domain of a cancer diagnosis: The impact of socioeconomic status and geographic location
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii569-viii570 (2018)

Anticoagulant treatment of patients (pts) with cancer associated thromboembolism (CAT) in Germany: Real world data from a 4 million people sample generated by insurance captured data
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii569 (2018)

Anti-tNASP antibodies as a diagnostic marker for malignant tumors
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii57 (2018)

EXPRESS study: A multicenter, prospective trial in progress exploring the association between low level of genomic alteration and exceptional and unexpected response to targeted therapies in patients with solid tumors
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii57 (2018 )

Neoadjuvant biomarker research study of palbociclib combined with endocrine therapy in estrogen receptor positive/HER2 negative breast cancer: The phase II NeoRHEA trial
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii57 (2018)

The quality oncology practice initiative program: Experience in Spain
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii570-viii571 (2018)

Overview on the use of patient reported outcomes in colorectal cancer care
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii570 (2018)

Completeness of staging investigation for colorectal cancer: Exploring the role of increasing age and comorbidity using mediation analysis
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii570 (2018)

Are treatment recommendations provided by cognitive computing supported by real world data (Watson for Oncology with Cota RWE) concordant with expert opinions?
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii571 (2018)

Treatment algorithm for multiple myeloma: Real-world insights across five European countries
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii571 (2018)

Body shape trajectories and risk of breast cancer: Results from the SUN study project
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii572 (2018)

No effect of length time bias on the genomic risk in ER+ HER2-stage I-IIA breast cancer (BC) patients according to diagnosis in a screening programme: An exploratory analysis
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii572-viii573 (2018)

Total polyphenol intake and breast cancer risk in the SUN project
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii572 (2018)

Malignant lymphoma detected by screening program with esophagogastroduodenoscopy of one private screening center in Japan
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii573 (2018)

Breast cancer screening: Impact on care pathways
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii573 (2018)

10-year results of the breast cancer screening program in Khanty-Mansiysk state region Ugra
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii573 (2018)

Gender difference in cancer survivors' perceived information 5-years after diagnosis: Data from the French national study - VICAN 5
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii574 (2018)

Referral patterns and predictors of survival for stage IV pancreatic ductal adenocarcinoma
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii574 (2018)

Survival difference between microscopically confirmed and microscopically non-confirmed cancers
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii575 (2018)

Outcome following unplanned excision in soft tissue sarcoma: Results of a multicentre study including 728 patients
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii576 (2018)

Initial results of phase I study of DCC-2618, a broad-spectrum KIT and PDGFRa inhibitor, in patients (pts) with gastrointestinal stromal tumor (GIST) by number of prior regimens
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii576-viii577 (2018)

Natural history of sarcomas and impact of reference centers in the nationwide NETSARC study on 35,784 patients (pts) from 2010 to 2017
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii576 (2018)

Health-related quality of life in patients with advanced soft tissue sarcoma (ASTS): Results from the TSAR randomized phase III trial of the French Sarcoma Group
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii577 (2018)

Health-related quality of life (HR-QoL) in elderly soft tissue sarcoma (STS) patients from the randomized phase II EPAZ study comparing pazopanib (PAZ) and doxorubicin (DOX) in first line
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii577 (2018)

Quality of life in patients with soft tissue sarcoma undergoing palliative treatment: A multicenter, cluster-randomized trial within the Germany Interdisciplinary Sarcoma Group (GISG-12)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii578 (2018)

Immune response, safety, and overall survival of NY-ESO-1+ soft tissue sarcoma patients treated with CMB305 therapy
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii578 (2018)

Can we cure patients with abdominal desmoplastic small round cell tumor? Results of a retrospective multicentric study on 100 patients
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii579 (2018)

Preoperative hypofractionated radiotherapy (RT) in patients with locally advanced myxoid liposarcomas: Interim analysis of prospective phase II clinical trial
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii579 (2018)

A phase II study of pazopanib with oral topotecan in patients with metastatic osteosarcoma
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii579 (2018)

Distant disease-free survival (DDFS) according to response category in neoadjuvant endocrine therapy (NET): 6-year analysis in phase III NEOS trial
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii58 (2018)

Tumor-infiltrating lymphocytes (TILs) as an independent prognostic factor for early HER2+ breast cancer patients treated with adjuvant chemotherapy and trastuzumab in the randomized shortHER trial
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii58-viii59 (2018)

A phase II, multicenter study of the EZH2 inhibitor tazemetostat in adults (rhabdoid tumor cohort) (NCT02601950)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii580-viii581 (2018)

A phase II, multicenter study of the EZH2 inhibitor tazemetostat in adults (INI1-negative tumors cohort) (NCT02601950)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii580 (2018)

A phase II, multicenter study of the EZH2 inhibitor tazemetostat in adults: Epithelioid sarcoma cohort (NCT02601950)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii581-viii582 (2018)

A phase II study of preoperative chemoradiation plus sorafenib (S) for high-risk extremity soft tissue sarcomas (STS)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii581 (2018)

MTOR inhibitors in uterine and extra-uterine malignant PEComas: A multicenter international case series retrospective analysis
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii581 (2018)

Multicentric retrospective analysis of patients with KIT exon 9 mutated GIST
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii582 (2018)

Prognostic factors for residual lesion surgery following disease control with standard dose imatinib (IM) treatment in patients (pts) with advanced gastrointestinal stromal tumor (GIST)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii582 (2018)

Quantitative multiplexed immune profiling of advanced gastrointestinal stromal tumors (GISTs): Impact of tyrosine kinase inhibitors on immune environment
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii582 (2018)

Systemic steroid treatment for severe skin rash induced by imatinib in patients with gastrointestinal stromal tumor (GIST): A phase II study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii583 (2018)

Heat shock protein 90 (HSP90) inhibitor as a candidate treatment option for gastrointestinal stromal tumor with acquired resistance for conventional receptor tyrosine kinase inhibitors
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii583 (2018)

Phase II study of paclitaxel in patients with advanced gastrointestinal stromal tumor (GIST) after failure of at least both imatinib and sunitinib
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii583 (2018)

Efficacy of metastasectomy on survival in patients with metachronous soft tissue sarcoma-metastasis: Results of a bi-centre study including 135 patients
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii584-viii585 (2018)

Pathological grade of tumorregression after neoadjuvant chemotherapy with doxorubicin/ifosfamid and regional hyperthermia correlates with survival outcomes in patients with high-risk soft tissue sarcoma
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii584 (2018)

Correlation of ctDNA and response in patients (pts) with PDGFRα D842 GIST treated with avapritinib
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii584 (2018)

Single arm prospective study evaluating the role of neoadjuvant chemotherapy in soft tissue sarcoma
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii585 (2018)

Preoperative hypofractionated radiotherapy (RT) combined with chemotherapy in primary marginally resectable high grade soft tissue sarcomas (STS) of extremities or trunk wall: Interim analysis of prospective phase II clinical trial
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii585-viii586 (2018)

Trabectedin and radiotherapy in advanced sarcoma: Experience of a reference center
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii585 (2018)

Efficacy of anlotinib in advanced soft tissue sarcoma by prior lines of therapy, age and dose modification
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii586 (2018)

Efficacy and safety of apatinib in advanced sarcoma
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii586-viii587 (2018)

Basket trial in advanced cancers: A clinical observation of apatinib in lung metastases and non-lung metastases
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii586 (2018)

Evaluation of hypertension and hand-foot syndrome as markers of anlotinib efficacy in advanced soft tissue sarcoma
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii587 (2018)

Perceptions of clinical trial enrollment in patients with bone and soft tissue sarcoma
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii587-viii588 (2018)

HBP-bound doxorubicin: Promising new therapy for bone cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii587 (2018)

Evolution of novel, low cost, sustainable osteosarcoma care over two decades: Reducing inefficiencies & improving outcomes
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii587 (2018)

Pneumothorax is a novel sensitivity biomarker for targeting VEGFR2 in lung metastatic sarcoma
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii588 (2018)

The study of molecular and genetic markers of apoptosis and proliferation, their role in the treatment and prevention of osteogenic sarcoma
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii588-viii589 (2018)

Outcome of treatment in giant cell tumors of bones: A single institutional retrospective review
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii589 (2018)

Pazopanib in advanced or metastatic synovial sarcoma: The Gustave Roussy experience
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii589-viii590 (2018)

Determination of biological behavior of solitary fibrous tumors
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii589 (2018)

Adriamycin and ifosfamide-based regimen as induction chemotherapy in desmoplastic small round cell tumors: Results of a retrospective single-center study on 34 patients
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii589 (2018)

High-dose chemotherapy (HDCT) with hematopoietic stem cell transplantation (HSCT) in high-risk breast cancer (BC) patients with ≥4 involved axillary lymph nodes (ALN): 20-year follow-up of a randomized phase 3 study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii59 (2018)

An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients (EORTC QLQ-BC23) - EORTC QLQ-BR45
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii59-viii60 (2018)

KS in the era of HAART: A single institutional retrospective review
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii590 (2018)

Carcinosarcoma: Clinical and epidemiological patterns in the United States
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii590 (2018)

First-line treatment of desmoid tumor: Systemic therapy versus upfront surgery
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii590-viii591 (2018)

Identification of effective drug combinations with regorafenib (REG) for the treatment of pediatric rhabdomyosarcomas (RMS)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii590 (2018)

A pan-cancer landscape analysis reveals a subset of endometrial stromal and pediatric tumors defined by internal tandem duplications of BCOR
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii591 (2018)

Adult rhabdomyosarcoma in Tunisia: Clinical presentation, treatment and outcome
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii591 (2018)

The efficacy of eribulin for patients with taxane-resistant cutaneous angiosarcoma: Interim result of multi-center, prospective observational study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii591-viii592 (2018)

Outcomes and prognostic factors for angiosarcoma: A 19-year single institution experience
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii592 (2018)

Management of locoregional recurrence after radical resection of a primary non-metastatic retroperitoneal soft tissue sarcoma: Results of a retrospective series in a tertiary care center
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii592 (2018)

Multicenter, open-label phase II study of daily oral regorafenib for chemotherapy-refractory, metastatic and locally advanced angiosarcoma
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii592 (2018)

Soft tissue sarcomas (STS) in elder patients: No impact of age on overall survival (OS) in an unselected cohort
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii593 (2018)

Should we consider altering our patterns of care for elderly sarcoma patients?
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii593 (2018)

Return to work and quality of life in disease-free adult sarcoma patients
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii593 (2018)

No benefit of preoperative chemotherapy for primary retroperitoneal sarcomas: Results from a single center propensity-matched analysis
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii593-viii594 (2018)

A randomized phase III study of denosumab before curettage for giant cell tumor of bone: Japan Clinical Oncology Group study JCOG1610
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii594-viii595 (2018)

The role of chemotherapy in the landscape of liposarcoma
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii594 (2018)

Combination of eribulin plus gemcitabine in L-sarcomas
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii594 (2018)

VOYAGER: An open-label, randomised, phase III study of avapritinib vs regorafenib in patients (pts) with locally advanced (adv) metastatic or unresectable gastrointestinal stromal tumour (GIST)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii595 (2018)

A randomized non-comparative phase II study of anti-PD-L1 ATEZOLIZUMAB or chemotherapy as second-line therapy in patients with small cell lung cancer: Results from the IFCT-1603 trial
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii596 (2018)

Preliminary efficacy of durvalumab plus tremelimumab in platinum-refractory/resistant ED-SCLC from arm A of the phase II BALTIC study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii596 (2018)

Impact of early prophylactic cranial irradiation with hippocampal avoidance on neurocognitive function in patients with limited disease small cell lung cancer: A multicenter phase II trial (SAKK 15/12)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii597 (2018)

Trilaciclib (T) decreases multi-lineage myelosuppression in extensive-stage small cell lung cancer (ES-SCLC) patients receiving first-line chemotherapy
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii597 (2018)

A pooled analysis of individual patient data (IPD) of concurrent chemoradiotherapy for limited-stage small cell lung cancer (LS-SCLC) in elderly compared to younger patients (pts) who participated in US National Cancer Institute cooperative group studies
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii597-viii598 (2018)

Treatment beyond four cycles of first line platinum and etoposide chemotherapy in real-life patients with stage IV small cell lung cancer: A retrospective study of the Merseyside and Cheshire cancer network
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii598 (2018)

Timing of treatment in small cell lung cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii598 (2018)

Trilaciclib (trila) preserves and enhances immune system function in extensive-stage small cell lung cancer (ES-SCLC) patients receiving first-line chemotherapy
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii598 (2018)

Maintenance treatment with the TLR9 agonist lefitolimod in extensive-stage small-cell lung cancer (ES-SCLC): Final results from the randomized phase II IMPULSE study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii599 (2018)

Phase II study of NAB-paclitaxel in sensitive and refractory relapsed SCLC (NABSTER TRIAL)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii599 (2018)

Safety of belotecan as second-line treatment for recurrent small cell lung cancer: A phase IIb randomized multicenter study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii599-viii600 (2018)

Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/AKT pathway
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii6 (2018)

Effect of the polymorphism rs2470893 of the CYP1A1 gene on ovarian and endometrial cancer in Mediterranean women
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii6 (2018)

Cisplatin in NIPEC or HIPEC?
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii6 (2018)

Matrix metalloproteinase-mediated regulation of programmed-death ligand in the human head and neck squamous cell carcinoma microenvironment
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii6 (2018)

Impact of nab-paclitaxel dose reduction on survival of the randomized phase III Gepar Septo trial comparing neoadjuvant chemotherapy of weekly nab-paclitaxel (nP) with solvent-based paclitaxel (P) followed by anthracycline/cyclophosphamide for patients with early breast cancer (BC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii60 (2018)

Tumor infiltrating lymphocytes predict benefit from TAC but not from ddAC in triple negative breast cancer in the randomized MATADOR trial (BOOG 2004-04)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii60 (2018)

UCHL1 has prognostic relevance and is a therapeutic target in high-grade neuroendocrine lung cancers
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii600 (2018)

Retrospective study of paclitaxel in advanced therapy lines in the treatment of SCLC
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii600 (2018)

Over-expression of shh is prognostic marker in patients with extensive stage small cell lung cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii600 (2018)

Robustness of DLL3 (SP347) immunohistochemistry assay for detection of DLL3 protein in small cell lung cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii600-viii601 (2018)

Nomogram for predicting the benefit of surgery for stage IA-IIB small cell lung cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii601 (2018)

Evaluation of practice patterns for prevention of chemotherapy (CT)-induced nausea and vomiting (CINV) and antiemetic guidelines (GLs) adherence based on real-world prescribing data
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii603 (2018)

Factors that influence oncology nutrition efficacy in breast cancer patients under antiestrogenic treatment
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii603-viii604 (2018)

Plinabulin (Plin), a novel non-G-CSF molecule for the revention of chemotherapy-induced neutropenia (CIN), has the potential to positively impact tumor micro environment
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii604 (2018)

Neuropathy and health behaviors in cancer survivors treated with chemotherapy (CT)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii604 (2018)

Effects of 6-month exercise training on quality of life in pancreatic cancer patients: Results from a randomized controlled trial
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii604 (2018)

Awareness of the cancer and non-cancer related harms of continued smoking in cancer survivors
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii605 (2018)

Acceptability in cancer outpatients of completing routine assessments of patient reported outcomes of common terminology criteria for adverse events (PRO-CTCAE) versus other patient reported symptom outcome tools
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii605 (2018)

Breast cancer (BC) related fatigue: A longitudinal investigation of its prevalence, domains and correlates
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii605 (2018)

Analysis of parameters to predict the effectiveness of scalp cooling to prevent chemotherapy-induced alopecia in breast cancer patients
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii606 (2018)

Physicians' knowledge, attitudes and practice towards fertility and pregnancy-related issues in BRCA-mutated breast cancer (BC) patients (pts): Results from the BCY3/BCC 2017 survey
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii606 (2018)

Updated meta-analysis of randomized controlled trials (RCTs) to determine the CDK 4/6 inhibitors associated venous thromboembolism (VTE) risk in hormone receptor-positive breast cancer (BC) patients
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii606 (2018)

A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA): Final study results
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii606-viii607 (2018)

Use of lipegfilgrastim for the prophylaxis of chemotherapy-induced neutropenia: Pan-European non-interventional study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii607-viii608 (2018)

Acupuncture for peripheral neuropathy in cancer patients: TCM diagnosis as a predictor of treatment response
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii607 (2018)

A randomized, open-label, non-inferiority study comparing the efficacy and safety of lipegfilgrastim versus pegfilgrastim in elderly patients with aggressive B-cell non-Hodgkin lymphomas (B-NHL): AVOID neutropenia
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii607 (2018)

New approach to evaluate survival benefit of granulocyte colony-stimulating factor in cancer patients receiving myelosuppressive chemotherapy
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii608 (2018)

Safe switch of treatment from the reference product to RGB-02, a proposed biosimilar pegfilgrastim: Analysis of the results of three clinical trials
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii608-viii609 (2018)

Safety analysis of proposed biosimilar pegfilgrastim in phase I and phase III studies
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii608 (2018)

Use of primary and secondary pegfilgrastim prophylaxis for reducing incidence of neutropenia: Findings from a large study in German clinical practice (PROTECT)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii609 (2018)

Associations between hematologic toxicity and health-related quality of life during first-line chemotherapy in advanced non-small-cell lung cancer: A pooled analysis of two randomized trials
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii609 (2018)

Incidence of hypocalcemia in a non-inferiority phase III trial assessing prevention of symptomatic skeletal events (SSE) with denosumab (DN) administered every 4 weeks (q4w) versus every 12 weeks (q12w): SAKK 96/12 (REDUSE)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii609-viii610 (2018)

Randomized trial of lisinopril or carvedilol for the prevention of cardiotoxicity in patients with early stage HER2-positive breast cancer receiving trastuzumab
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii61 (2018)

Research-based PAM50 predicts risk of relapse in residual disease after anti-HER2 therapies
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii61 (2018)

Real-life utilization of genomic testing for invasive breast cancer patients in Italy and France reduces chemotherapy recommendations
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii61 (2018)

Ramosetron versus palonosetron in combination with aprepitant and dexamethasone for the control of highly emetogenic chemotherapy-induced nausea and vomiting
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii610 (2018)

A prospective randomized controlled trial of metoclopramide combined with triple antiemetic therapy to prevent anthracycline-based chemotherapy-induced nausea and vomiting in patients with breast cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii610 (2018)

Assessment and treatment of breakthrough cancer pain in Spain: A self-audit study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii611-viii612 (2018)

Analysis of bone events in patients with aromatase inhibitors (AI)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii611 (2018)

Usefulness of bone modifying agents for non-weight bearing bone metastasis in breast cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii611 (2018)

Prognostic factors associated with prevalence of nausea, and time to development of nausea in patients receiving guideline-based anti-emetic prophylaxis: A prospective, observational, real world study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii611 (2018)

Efficacy and tolerability of naldemedine in patient with cancer and opioid-induced constipation: A pooled subgroup analysis of 2 randomized placebo-controlled studies
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii612 (2018)

Opioid-induced constipation in patients with cancer pain in Japan: Prospective observational study using Rome IV OIC diagnostic criteria (OIC-J Study)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii612 (2018)

Clinical practice evaluation of opioids induced constipation management in oncologic patients: The EIO-50 project
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii612 (2018)

Baseline prevalence of cardiovascular disease (CVD) risk factors in women with breast cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii613 (2018)

Predicting the occurrence and prevention of early anthracycline cardiotoxicity of chemotherapy in patients with breast cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii613 (2018)

Left ventricular ejection fraction (LVEF) change for the first 6 months predicts development of trastuzumab-related cardiotoxicity in patients with breast cancer: An implication for the more efficient cardiac surveillance
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii613 (2018)

Prevention and prophylaxis of thrombosis in cancer patients
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii614 (2018)

The incidence of recurrent venous thromboembolism (VTE) and bleeding depending on practical treatment pattern of anticoagulation in the cancer patients with VTE
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii614 (2018)

Systematic literature review and network meta-analysis of oral anticoagulants for the treatment of venous thromboembolism in patients with cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii615 (2018)

Is it appropriate to use a fixed prophylactic dose of enoxaparin for hospitalized cancer patients? Results from a prospective tertiary referral single center study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii615 (2018)

Comparison of venous thromboembolism risk assessment models in patients receiving chemotherapy
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii615-viii616 (2018)

Long-term prognosis of acute pulmonary embolism: A focus on idiopathic and neoplastic etiologies
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii615 (2018)

Role of megestrol acetate versus dexamethasone for improvement in appetite in patients with cancer associated anorexia cachexia: A randomized controlled pilot trial
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii616 (2018)

Population pharmacokinetics (PPK) of anamorelin (ANAM), an oral selective ghrelin receptor agonist
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii616-viii617 (2018)

Personalised nutritional care during chemotherapy using survey on taste changes during chemotherapy: First experience from tertiary chemotherapy day care center in Northern India
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii616 (2018)

Health care providers' experiences of positive and negative effects of parenteral nutrition therapy in cancer patients
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii617 (2018)

Body composition factor is independent prognosticator in advanced pancreatic cancer patients
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii617 (2018)

Assessment of anorexia and weight loss in newly diagnosed upper gastrointestinal cancer patients with localised and metastatic disease, using the functional assessment of anorexia cachexia therapy anorexia/cachexia subscale (FAACT A/CS)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii617 (2018)

Nutritional cancer care: Slowly evolving clinical practice reveals regional and professional HCP variability
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii618 (2018)

Current use of clinical nutrition in oncology patients: Real world evidence from big data in Italy
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii618 (2018)

Unidentified cachexia patients in the oncologic setting: Cachexia UFO's do exist
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii618 (2018)

The effect of sarcopenia on acute chemotherapy toxicity in gastrointestinal cancer patients undergoing systemic therapy
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii618-viii619 (2018)

Early detection of skeletal muscle atrophy using a multiple plasma-free amino acid index in the advanced aged patients with advanced pancreatic cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii619 (2018)

Trajectory of skeletal muscle index (SMI) loss during palliative systemic treatment (Tx) predicts time to progression (TTP) in metastatic colorectal cancer (mCRC) patients
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii619 (2018)

Clinical impact of whey protein and nutritional counseling in gastrointestinal cancer patients
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii619-viii620 (2018)

Benefit of adjuvant chemotherapy in hormone receptor-positive, HER2-negative, invasive lobular carcinoma of the breast
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii62 (2018)

Baseline lymphocyte counts predict distant recurrence in early breast cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii62-viii63 (2018)

Impact of taste alterations during systemic anti-tumour therapy on the liking of oral nutritional supplements with adapted flavours
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii620 (2018)

Overweight, obesity and weight gain after breast cancer (BC): A prospective clinical study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii620-viii621 (2018)

Weight loss, physical and psychological patient reported outcomes (PROs) among obese patients (pts) with early breast cancer (BC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii621 (2018)

Patient reported outcomes: Web-monitoring versus nurse assessment to improve anticancer therapies
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii621-viii622 (2018)

Developing a predictive model for chemotherapy related toxicities in older Asian adults
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii622-viii623 (2018)

Polymedication in elderly cancer patients treated with chemotherapy
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii622 (2018)

Geriatric oncology (GO): Long term follow-up of a prospective series of the GO unit at A.C. Camargo Cancer Center
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii622 (2018)

Comparing cancer patients' and support persons' preferences for the type of consultation and the format of information provided when making a treatment decision
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii623 (2018)

General and dedicated cancer emergency room: Clinical and financial implications
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii623 (2018)

EXTEND: Safety and efficacy of exercise training in men receiving enzalutamide (ENZ) in combination with conventional androgen deprivation therapy (ADT) for hormone naïve prostate cancer (HSPC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii623-viii624 (2018)

Palliative local therapy of advanced breast cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii623 (2018)

Ultrasound-guided femoro-popliteal block in lower limb sarcoma and cutaneous malignancy patients: Is it the time to abandon spinal anaesthesia for foot and ankle surgeries?
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii624 (2018)

Cancer care-related social media (SM) and internet usage differences between adolescents and young adults (AYA), adults and elderly patients with cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii624 (2018)

Assessment of socio-economic, physical and mental health status of long-term cancer survivors
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii624-viii625 (2018)

Prognostic factors for critically ill patients with solid cancer tumours admitted to a medical intensive care unit
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii625-viii626 (2018)

Monitoring quality of life in Dutch women with breast cancer: The Care Notebook study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii625 (2018)

Usability testing of EirV3-a computer-based tool for patient reported outcome measures in cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii625 (2018)

A pilot study of exercise intervention in patients with metastatic cancer: Feasibility, safety, and patient reported outcome
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii626 (2018)

High proportion of prostate cancer survivors continue to experience a negative impact on quality of life long after diagnosis: Patient reported outcomes for an Australian population-based sample
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii626-viii627 (2018)

Characterisation of oncologic patient visits at the ED at an Austrian tertiary care center
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii626 (2018)

A prospective analysis of 30-day mortality following palliative chemotherapy at an Australian tertiary cancer centre
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii626 (2018)

A systematic approach to smoking cessation in regional cancer centres in Ontario, Canada
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii627 (2018)

A longitudinal study of a new point-of-care nerve conduction device for quantitative assessment of chemotherapy-induced peripheral neurotoxicity
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii627 (2018)

Risk of health-related quality of life events and pulmonary toxicities in recurrent ovarian cancer patients treated with poly adenosine diphosphate ribose polymerase (PARP) inhibitors maintenance
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii627-viii628 (2018)

Chemotherapy-induced peripheral neurotoxicity (CIPN): What are patients telling us?
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii628 (2018)

Malnutrition in cancer patients: Is late diagnosis a missed opportunity to improve care?
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii628 (2018)

Novel approach for counselling of young cancer patients
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii629-viii630 (2018)

Sexual functioning and depression among Egyptian breast cancer patients following surgery and neoadjuvant/adjuvant chemotherapy
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii629 (2018)

Supportive care: Patient expectations, availability and uptake
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii629 (2018)

Benefit of adjuvant systemic therapies in HR+ HER2- pT1ab node-negative breast carcinomas
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii63 (2018)

A propensity score analysis exploring the impact of the addition of adjuvant chemotherapy (aCT) to hormone therapy (aHT) in a multi-center series of resected luminal early stage pure invasive lobular breast carcinoma (ILC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii63 (2018)

Immune related adverse events across cancer types: Incidence, risk factors and survival
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii630-viii631 (2018)

Hypothyroidism in cancer patients received multikinase inhibitors: Risk factors and outcomes
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii630 (2018)

Health-related quality of life priorities in adolescents and young adults (AYA) with cancer: Discrepancies with health care professionals' perceptions
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii630 (2018)

What information and features do young and older adults with cancer want in their hospital-based social media cancer resource?
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii630 (2018)

Effect of yoga on chemo-radiotherapy induced diabetes and hypertension (CRID-H) among cervical cancer patients at a regional cancer institute in south India
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii631 (2018)

Acute toxicity of concurrent radiochemotherapy for locally advanced head and neck cancer: A prospective study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii631-viii632 (2018)

Fatigue prevalence and adherence to treatment: A real-world data survey and mathematical model application
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii631 (2018)

Chemotherapy effect on daytime sleepiness and contributing factors in older adults with cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii632 (2018)

Group pre-chemotherapy education: Improving patient experience through education and empowerment
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii632 (2018)

Clinical and psychometric validation of the BreSAS questionnaire for symptom assessment among breast cancer survivors
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii632 (2018)

Hepatitis screening for patients to undergo chemotherapy in Cyprus
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii633 (2018)

Hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) screening prior to chemotherapy initiation among patients with solid tumors
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii633 (2018)

Rapid identification of bloodstream infection pathogens
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii633-viii634 (2018)

Association of phase angle and chemotherapy toxicity among Mexican patients with non-metastatic breast cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii633 (2018)

Antiviral prophylaxis cannot reduce the risk of hepatitis B reactivation during chemotherapy for non-HCC solid tumor patients with lower HBV DNA titer: A retrospective cohort study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii634 (2018)

Prospective observational study to evaluate the persistence of treatment with denosumab (dmab) in patients (pts) with bone metastases (BM) from solid tumors (ST) in routine clinical practice: Final analysis
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii634-viii635 (2018)

Pathogens and characteristics of candidemia in hospitals of Rostov-on-Don: Multicenter study in Russia
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii634 (2018)

Correlation between fatigue evaluated with a visual analog scale (VAS) and quality of life (QoL) in cancer patients treated with biosimilar epoetin alfa for chemotherapy-induced anemia (CIA): The CIROCO study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii635 (2018)

Quality of life, late effects, and related clinical factors among Korean colorectal cancer survivors
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii635-viii636 (2018)

A multicenter retrospective investigation on the efficacy of perioperative oral management in cancer patients
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii635 (2018)

Comparison of palonosetron and granisetron in triplet antiemetic therapy in nonmetastatic breast cancer patients receiving high emetogenic chemotherapy. A multicenter, prospective, and observational study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii636 (2018)

Painkiller-related dizziness in malignant tumors: A systematic review
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii636 (2018)

Prevalence, risk factors and management of opioid-induced constipation in cancer pain: A nationwide, cross-sectional study in Korea
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii636 (2018)

Bald is beautiful: No more. The stigma of alopecia during chemotherapy: Brindisi oncology department experience
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii637 (2018)

Quality of life in breast cancer Tunisian women: A monocentric survey
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii637 (2018)

Anticancer therapy within the last 30 days of life in a regional cancer centre
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii637-viii638 (2018)

A large multi-center, randomized, double-blind, crossover study in healthy volunteers to compare pharmacokinetics and pharmacodynamics of a proposed biosimilar pegfilgrastim with EU and US reference pegfilgrastim: Methodological approach
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii637 (2018)

Novel online drug-drug interaction resource reveals clinically relevant interactions in>20% of the searches
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii638 (2018)

Febrile neutropenia management and concordance of institutional protocol with clinical practice
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii638 (2018)

Salient features of an indigenous integrated inpatient model of delivery of supportive medicine services: A narrative review
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii638 (2018)

The concordance with antiemetic guideline for pediatric, adolescent and young adult patients with cancer using a large-scale administrative database
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii639 (2018)

Effectiveness of surgical glove compression therapy as a prophylactic method against nab-paclitaxel induced peripheral neuropathy
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii639 (2018)

Clinicopathologic significance of androgen receptor expression and discordant receptor status during progression in breast cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii64 (2018)

Anti-proliferative effect of oral metronomic vinorelbine in PAM50 Luminal/HER2-negative early breast cancer (SOLTI-1501 VENTANA): An open-label, randomized, three-arm, multicenter, window-of-opportunity study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii64 (2018)

The outcomes of early breast cancers utilizing the oncotype Dx recurrence score (RS) instead of clinico-pathological (CP) factors for prognostic risk assessment: A single institution experience
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii64 (2018)

Circulating tumor cells as a prognostic marker in non-metastatic breast cancer patients
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii64-viii65 (2018)

Pilot and definitive randomised double-blind placebo-controlled trials evaluating an oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting (CINV)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii640 (2018)

Effect of oral magnesium supplementation on the kinetics of magnesium wasting induced by EGFR targeted antibody therapy for colorectal carcinoma (MAGNET trial)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii640 (2018)

STELLAR: Final results of a phase II trial of TTFields with chemotherapy for first-line treatment of pleural mesothelioma
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii641 (2018)

Multiple primary cancers (MPC) in a series of lung cancer (LC) patient: Incidence and outcome
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii641 (2018)

Role of evaluating tumor infiltrating lymphocytes, programmed death-ligand 1 and mismatch-repair proteins expression in malignant mesothelioma
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii641-viii642 (2018)

Clinicopathological features of thymoma with the expression of programmed death-ligand 1
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii642 (2018)

Elective nodal irradiation as adjuvant radiotherapy for advanced thymomas and thymic carcinomas
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii642 (2018)

The impact of PD-L1, TGF-β expression and tumor-infiltrating CD8+ T cells on clinical outcome of patients with advanced thymic epithelial tumors
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii642-viii643 (2018)

Development and validation of a deep learning model using biomarkers in pleural effusion for prediction of malignant pleural mesothelioma
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii642 (2018)

Comparative proteomic analysis of acetylation profiles in esophageal squamous carcinoma cells
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii643 (2018)

Prevalence and prognostic value of PD-L1 expression in molecular subtypes of metastatic large cell neuroendocrine carcinoma (LCNEC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii643 (2018)

Computed tomography features of resected lung adenocarcinomas with spread through air spaces
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii643 (2018)

Multicentre, double-blind, randomised phase II study evaluating gemcitabine with or without ramucirumab as II line treatment for MPM
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii644 (2018)

SAKK 17/16 - Lurbinectedin monotherapy in patients with progressive malignant pleural mesothelioma: A multicenter, single-arm phase II trial
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii644 (2018)

Survival outcomes for patients with lobectomy and wedge resection in lung cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii644 (2018)

Updated efficacy and safety data of dabrafenib (D) and trametinib (T) in patients (pts) with BRAF V600E-mutated anaplastic thyroid cancer (ATC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii645-viii646 (2018)

Synergistic anti-cancer activity of tyrosine kinase inhibitors and paclitaxel with radiation on anaplastic thyroid cancer in vitro and in vivo
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii645 (2018)

Tumor growth rate and lenvatinib efficacy in radioiodine-refractory differentiated thyroid cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii645 (2018)

Synergistic anti-cancer effect of histone deacetylase inhibition and blockade of the glycolytic pathway
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii646 (2018)

Lenvatinib and pembrolizumab as save and effective combination treatment in 8 patients with metastasized anaplastic (ATC) or poorly differentiated thyroid carcinoma (PDTC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii646 (2018)

Both HIF-1α and GAB1 can regulate pim-1 in the papillary thyroid carcinoma
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii646-viii647 (2018)

Increase in thyroid cancer (TC) incidence in Cyprus: Overdiagnosis or true increase of clinically relevant TC?
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii647 (2018)

Surgery for lymph node metastases of sporadic medullary thyroid carcinoma
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii647 (2018)

A noninferiority trial of cabozantinib (C) comparing 60mg vs 140mg orally per day to evaluate the efficacy and safety in patients (pts) with progressive, metastatic medullary thyroid cancer (MTC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii647-viii648 (2018)

Role of SPECT-CT somatostatin-receptor scintigraphy in the management of medullary thyroid cancer (MTC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii647 (2018)

Molecular differences between colorectal cancers with mutations in histone modifiers genes vs wild-type (WT) tumors
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii649 (2018)

Liquid biopsy as tool to monitor and predict clinical benefit from chemotherapy (CT) and immunotherapy (IT) in advanced non-small cell lung cancer (aNSCLC): A prospective study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii649 (2018)

Phase I study of CC-90011 in patients with advanced solid tumors and relapsed/refractory non-Hodgkin lymphoma (R/R NHL)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii649-viii650 (2018)

Analytical validation of OncoMasTR, a multigene test for predicting risk of distant recurrence in hormone receptor-positive early stage breast cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii65 (2018)

Molecular subtyping of breast cancer by dedicated breast PET
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii65 (2018)

Comparative molecular analysis between microsatellite instability-high (MSI-H) tumors with high tumor mutational burden (TMB-H) versus MSI-H tumors with TMB-intermediate/low
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii650-viii651 (2018)

Genomic profile and T cell receptor repertoire of lung adenosquamous carcinomas
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii650 (2018)

Lack of efficiency of precision oncology with target-based investigational treatments for patients in early phase clinical trials based on pre-screened molecular alterations
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii650 (2018)

Characterization through whole exome sequencing of individuals presenting extreme phenotypes of high and low risk to develop tobacco-induced non-small lung cancer (NSCLC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii651-viii652 (2018)

Representative sequencing: Profiling extreme tumor diversity
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii651 (2018)

Whole-exome cfDNA profiling captures the mutational signatures of metastatic breast cancer for monitoring disease evolution
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii652 (2018)

Preclinical evaluation of a non-depleting, first-in-class humanized IgG4 agonist anti-ICOS antibody
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii652-viii653 (2018)

CANscript™ as a patient-derived predictive platform for individualizing treatment in lung cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii652 (2018)

Foretinib circumvents the NTRK1 G667C mutation-associated entrectinib-resistance in the brain and liver metastases produced by NTRK1 fusion-positive tumor cells
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii653 (2018)

Refining criteria of hyperprogression (HPD) with immune checkpoint inhibitors (ICIs) to improve clinical applicability
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii653 (2018)

Molecular alterations and matched treatment in older patients: Results from the MOSCATO 01 trial
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii653-viii654 (2018)

Prognostic implications of mismatch repair deficiency in patients with early-stage colorectal and endometrial cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii654 (2018)

Safety, clinical activity and pharmacological biomarker evaluation of the DNA-dependent protein kinase (DNA-PK) inhibitor M3814: Results from two phase I trials
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii654 (2018)

Role of TP53 mutations in relation to response to anti-ALK agents in EML4-ALK-translocated NSCLC patients
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii654 (2018)

Meta-enrichment analysis to identify a higher response patient population to S-1/cisplatin for advanced gastric cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii655 (2018)

ATR inhibition with radiation creates an inflammatory tumour microenvironment
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii655 (2018)

Predictive significance of tumour angiogenic and anti-angiogenic VEGF-A splice variants in patients with metastatic colorectal cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii655 (2018)

RNA-based analysis of anaplastic lymphoma kinase (ALK) fusions in non-small cell lung cancer (NSCLC) cases showing immunohistochemistry/fluorescence in-situ hybridisation (IHC/FISH) discordance
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii656 (2018)

The combination of MEK inhibitor and anti PD-L1: Effects on organoid models from NSCLC biopsies
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii656 (2018)

Intraoperative fluorescent image-guided detection of esophageal cancer in rabbit and patient specimens
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii656 (2018 )

Interaction between cancer associated fibroblasts and cancer cells influence immune infiltrate and is modulated by therapeutic agents
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii657 (2018)

Dynamic change of immune-related gene expression status during chemoradiotherapy in locally advanced esophageal cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii657 (2018)

CD5 and CD6: Evaluation of their role as prognostic biomarkers in resectable non-small cell lung cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii657 (2018)

Identification of the rational combination of two epigenetic inhibitors therapy in refractory AML using patient tumor derived ex vivo platform
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii658 (2018)

Tyrosine kinase inhibitors and acid-inhibitory drugs: Strong concomitant dispensing and drug-drug interaction risk
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii658 (2018)

Proteomic-based machine learning computational analysis discovered biomarkers of aberrant vesicle-exosomal trafficking to determine chemotherapeutic responses in breast cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii658-viii659 (2018)

Intraoperative detection of resection margin by inhalation of ICG in lung cancer preclinical study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii658 (2018)

Pre-treatment circulating cytokines predict toxicity with combination anti-PD1 and anti-CTLA4 immunotherapy
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii659 (2018)

Carcinoma of unknown origin: Deep genomic profile helps to achieve an accurate diagnosis
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii659 (2018)

A phase I trial of vorolanib (X-82t vascular endothelial growth factor receptor (VEGFR) inhibitor, in patients (pts) with advanced solid tumors
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii659-viii660 (2018)

The impact of the 21 gene recurrence score (RS) on chemotherapy (CHemoRx) prescribing in hormone receptor (HR) positive, lymph node positive (LN+) early-stage breast cancer (BC) in Ireland: A national, multi-centre, prospective study (CTRIAL-IE 15-34)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii66-viii67 (2018)

Genomic spectrum of Asian breast cancer based on targeted next-generation sequencing in 150 consecutive primary breast cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii66 (2018)

TNBC universe: A monocentric retrospective analyses of TILs and AR as prognostic markers
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii66 (2018)

Longitudinal analysis of circulating biomarkers to monitor advanced EGFR mutated (EGFR+) non-small cell lung cancer (NSCLC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii660 (2018)

Genotyping of circulating tumor DNA in biliary tract cancer reveals diagnostic and prognostic information
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii660 (2018)

Interactions of cancer stem cell and immune microenvironment in non-small cell lung cancer (NSCLC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii660-viii661 (2018)

A genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii661-viii662 (2018)

Circulating tumour DNA (ctDNA) as a tool to assess response and guide therapy adaptation in rectal cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii661 (2018)

Association of the rs1883832 variant of CD40 with NSCLC risk and overall survival
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii661 (2018)

Phase I pharmacological study of continuous chronomodulated capecitabine treatment
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii662-viii663 (2018)

Survival from breast cancer in patients with BRCA1/2, CHEK2, NOD2 mutations and TP53 (c.[215G>C]) polymorphisms
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii662 (2018)

Effect of a combined treatment with iPS cells derived dendritic cells and proton beam irradiation in a murine subcutaneous melanoma model
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii662 (2018)

Developing the liquid biopsy in gastroesophageal adenocarcinoma: Disease monitoring and detection of minimal residual disease
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii662 (2018)

Head and neck (HN) primary sarcomatoid carcinoma (PSC) profile by high-throughput somatic mutation profiling
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii663 (2018)

A composite liquid biomarker for non-invasive diagnosis of resectable pancreatic ductal adenocarcinoma
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii663 (2018)

Acquired chemoresistance of colorectal cancer (CRC) cells is accompanied by pro-invasive VEGF-signaling that can be attenuated by aflibercept
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii663-viii664 (2018)

DNA repair genetic profiling in epithelial ovarian cancer: An opportunity for clinical improvement?
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii664-viii665 (2018)

Actionable mutations and overall survival in 3,211 patients with cancer: The Hellenic cooperative oncology group precision medicine initiative
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii664 (2018)

Potential role of RICTOR copy number gain (CNG) as a key biomarker of mTOR activity: A comprehensive preclinical analysis in squamous cell lung cancer (SQLC) models
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii665 (2018)

Strategy to improve the antitumor efficacy of dendritic cell-based nanovaccine under magnetic field control
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii665 (2018)

Final results of the phase I study in healthy volunteers of AB928, a dual antagonist of the A2aR and A2bR adenosine receptors being studied as an activator of anti-tumor immune response
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii665 (2018)

Liprin-alpha4 contributes to increased proliferation and decreased chemosensitivity under hypoxia for small cell lung cancer as a downstream mediator of HIF-1alphaα
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii666-viii667 (2018)

PBRM1 is a novel candidate low-penetrance familial cancer predisposition gene
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii666 (2018)

An expression signature characterizes cancer stem cells from lung adenocarcinoma patients
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii666 (2018)

Development of primary human NSCLC patient derived xenograft and organoids models as a precision approach to tumor treatment
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii666 (2018)

Prediction of response to vemurafenib in BRAF V600E mutant cancers based on a network approach
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii667-viii668 (2018)

Streamlining multi-omic and artificial intelligence analysis through interrogative biology and baicis for translational precision medicine applications in clinical oncology
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii667 (2018)

Precision medicine for patients with rare cancers: An effective strategy within the prospective MOSCATO trial
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii667 (2018)

Improving value for cancer patients: A European study of outcomes in practice
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii668 (2018)

High-throughput screening of new drugs targeting lung CSCs
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii668 (2018)

RING observational trial to compare T790M mutation testing in blood by different methodologies
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii669 (2018)

Lymphocyte-predominant breast cancer has a significant lower mean of absolute neutrophil counts compared to non-lymphocyte-predominant breast cancer: Analyses with 576 cases
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii67 (2018)

Genetic alterations of early-stage breast cancers by next-generation sequencing (NGS)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii67 (2018)

Oncotype Dx results in patients ≤40 years: Does age matter? New insights
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii67-viii68 (2018)

Single-cell RNA sequencing of triple negative breast cancer patient-derived xenograft reveals distinct cellular populations spatially mapped to histological sections
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii670-viii671 (2018)

Molecular characterization of epithelioid sarcoma (ES) tumors derived from patients enrolled in a phase II study of tazemetostat (NCT02601950)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii670 (2018)

A joint metabolic profile of plasma and tissue samples or discovering novel biomarkers in breast cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii670 (2018)

Joined analysis of sarcomatoid carcinoma (SC) mutational profiles: Comparison of lung versus head and neck cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii671 (2018)

Homology-directed repair (HDR)-defective lung adenocarcinomas (LUACs) in circulating tumor DNA (ctDNA)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii671 (2018)

Real-world prospective data of small biopsy samples for tumor PD-L1 expression in non-small cell lung cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii672-viii673 (2018)

Differential expression of immune checkpoints (PD-L1, HHLA2, B7x and B7H3) and their association with driver mutations in pulmonary sarcomatoid carcinoma (PSC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii672 (2018)

The role of SWI/SNF chromatin remodelling complex ATPase subunit - BRM in TNBC
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii672 (2018)

Fluoropyrimidine and inflammatory genes promoter methylation in Egyptian CRC patients
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii672 (2018)

BRCA mutation and castration-resistant prostate cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii673 (2018)

ATM as a DNA damage response protein in uveal melanoma: Association with clinicopathological factors and prognostic outcome
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii673 (2018)

Prevalence of KRAS mutation subtypes and MSI status in pancreatic cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii673 (2018)

Discordance of the PAM50 intrinsic subtypes compared with IHC-based surrogate in breast cancer patients: Potential implication of genomic alterations of discordance
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii674-viii675 (2018)

Lung cancer predisposition in women with previous breast cancer identified by whole exome sequencing
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii674 (2018)

Molecular signature in malignant pleural mesothelioma (MPM): Preliminary data of Italian RAMES study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii674 (2018)

N-Myc and STAT interactor (NMI) as a key determinant of chemosensitivity in breast cancer: Proteomic-based computing network mapping and in vivo verification with a mouse model
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii674 (2018)

Clinical validation of an NGS-based assay for the detection of BRCA1 and BRCA2 variants in Chinese patients with breast cancer or ovarian cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii675 (2018)

Correlation beetween the expression of androgens receptor (RA) and histopathological characteristics and survival parameters of breast cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii675-viii676 (2018)

HER2 staining intensity has prognostic impact on patients with HER2 type invasive breast cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii676-viii677 (2018)

A guided and personalised treatment in metastatic breast cancer: Optimisation of gene and protein expression in tumor tissue
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii676 (2018)

Metabolic syndrome in breast cancer patients: An observational study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii676 (2018)

The prognostic value of different molecular subtypes of breast cancer in relation to enhancer-of-zeste homologue 2 expression
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii676 (2018)

Does the minimal axillary approach lead to loss of prognostic factors in breast cancer?
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii677 (2018)

The influence of the surgical approach in women diagnosed with breast neoplasia
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii677 (2018)

Use of comparative proteomics to identify potential cisplatin-resistance mechanisms in neuroblastoma
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii677 (2018)

Acquired resistance mechanism of osimertinib targeting EGFR in human lung cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii677-viii678 (2018)

Role of pioglitazone on gene/protein expression profile, bioenergetics and TGFβ/SMAD signaling pathway in NSCLC
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii678 (2018)

Somatostatin receptor 2 expression and clinical significance in pulmonary lymphoepithelioma-like carcinoma
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii678 (2018)

The role of neurotrophic factors in nerve-cancer crosstalk
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii678-viii679 (2018)

Interaction of oncostatin M and its receptor OSMR promotes gastric cancer progression via STAT3/FAK/Src signaling
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii678 (2018)

FAM115c that upregulates proliferation and invasion under hypoxia could be a predictive biomarker for pancreatic cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii679-viii680 (2018)

Survival analysis of sorafenib in hepatocellular carcinoma patients with microvascular invasion after hepatectomy
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii679 (2018)

Combining 2D angiogenesis and 3D osteosarcoma microtissues to improve vascularization
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii679 (2018)

Glutathione S-transferase M subfamily in TMZ-resistant glioblastoma cells
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii679 (2018)

Impact of BRCA status on outcomes and survival in high-risk early breast cancers
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii68 (2018)

Ki67 as an important predictor for oncotype Dx recurrence score risk groups in early breast cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii68 (2018)

Early breast cancer classified as intermediate risk by the Prosigna assay: Characteristics and treatment strategy
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii68 (2018)

Chemokine receptor CXCR7 expression, function and clinical implications in head and neck squamous cell carcinoma
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii680-viii681 (2018)

Pathologic assessment following neoadjuvant immunotherapy or chemotherapy demonstrates similar patterns in non-small cell lung cancer (NSCLC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii680 (2018)

Tumor-infiltrating CD3+ lymphocytes and ICOS+ T-cells predict a favorable survival in resected esophageal squamous cell carcinoma
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii680 (2018)

Pulmonary tumor thrombotic microangiopathy (PTTM): 24 case series and its criteria for pathological diagnosis
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii681 (2018)

Autofluorescence: A new marker for identifying cancer stem cells (CSCs) in primary tumors
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii681-viii682 (2018)

Assessment of PD-1/PD-L1 colocalization in hepatocellular carcinoma (HCC) using bright-field double labeling and quantitative digital image analysis
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii681 (2018)

Somatic-stem transition of tumor cells is a key link in the metastasis
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii682 (2018)

Survival effect of lncRNA-X expression in EGFR-mutant adenocarcinoma
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii682 (2018)

Nurse navigators in thoracic oncology: A qualitative study of German nurses' attitudes to nursing role expansion
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii683-viii684 (2018)

Evaluation of an education programme on compassion fatigue: Turkish oncology-haematology nurses' perspectives
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii683 (2018)

The efficacy of nurse-led clinic
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii683 (2018)

Introducing the role of the advanced clinical practitioner in haematology and oncology
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii683 (2018)

Perceptions of rural nurses extending their role to administer chemotherapy
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii684 (2018)

BRAF/MEK-inhibition for patients with metastatic melanoma: Towards patient-centered care
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii684 (2018)

Patients: Power sources for cancer nurses
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii684 (2018)

Introducing a new role in cancer care, coordinating contact nurses: Patient-reported evaluation
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii685 (2018)

The role of the nurse in the detection of geriatric frailty and the risk of chemotherapy toxicity in elderly patients with cancer: Preliminary study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii685 (2018)

Systemic anticancer therapy administration safety
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii685 (2018)

Nurse led follow-up for CML patients on oral cancer treatment
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii685 (2018)

Introducing cancer nurse led consultations to improve sexuality & fertility outcomes for adolescents and young adults (AYAs) with an hematological disease
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii686 (2018)

Opinions and experiences of patients receiving oral chemotherapy: A qualitative study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii686 (2018)

Increasing incidence and prevalence of immune-related adrenal insufficiency in patients with cancer: The role of the nurse practitioner for early recognition and management
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii686 (2018)

Experiences from a new advanced cancer nursing role in Sweden: An analysis based on EONS Cancer nursing education framework using the Delphi method
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii686 (2018)

Are there differences between nurses' and patients' perceptions of cancer patients' quality of life in Greece?
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii687 (2018)

How an empowerment program can touch cancer survivor's life by improving post-traumatic growth?
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii687 (2018)

Organising a general oncology nursing outpatient clinic
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii687 (2018)

Standardising the psychosocial assessment of oncological patients at Donostia university hospital
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii687 (2018)

Job content of advanced practice nurses in Flanders
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii688 (2018)

Supporting melanoma patients and their carers: A qualitative exploration of social interaction between patients, carers and healthcare professionals
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii688 (2018)

Developing and testing a theory-based e-learning intervention to enhance healthcare professional's self-efficacy when supporting parents newly diagnosed with cancer who have dependent children
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii688 (2018)

Assessing the effect of telephone support on patients with myeloma multiple (MM) in the Catalan oncology institut in Girona
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii688 (2018)

The cost of survival: A mixed-method exploration of healthcare-related factors predicting colorectal cancer survivors' quality of life
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii689 (2018)

The influence of social networks on cancer survivors' self-management support: A survey analysis
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii689 (2018)

Transmural collaborative care in oncology: Experiences of general practitioners
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii689-viii690 (2018)

Significance of receptors expression, mitotic index and Ki67 in breast cancer patients with Nottingham Prognostic Index (NPI) poor prognosis score
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii69 (2018)

Genetic signatures always suggest undertreatment? Experience with PAM50
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii69 (2018)

Subgroup analyses of efficacy from a phase III study comparing SB3 (trastuzumab biosimilar) with reference trastuzumab in early breast cancer patients
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii69 (2018)

Most prevalent unmet supportive care needs in Greek ambulatory advanced breast cancer female patients receiving chemotherapy
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii690-viii691 (2018)

Comparing nurses' and patients' research priorities in cancer care: A mixed methods systematic review
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii690 (2018)

Laryngectomized patients caregivers' life experience: A phenomenological study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii690 (2018)

The use of patient reported outcome (PRO) instruments in immune checkpoint inhibitor (ICI) therapy for cancer: A systematic review
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii690 (2018)

Does being cancer patient or family caregiver of cancer patient effect bone marrow donation awareness?
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii691 (2018)

A review of the challenges faced by carers of patients diagnosed with head and neck cancer before, during and after treatment
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii691-viii692 (2018)

Individual network meetings in cancer care: From young people with cancer to adults with brain tumours
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii691 (2018)

A new beginning of collaboration: The Danish Cancer Nursing Research Network
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii691 (2018)

Dignity of Greek patients with advanced cancer: A cross-sectional study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii692 (2018)

Evaluation of support and information needs for patients with cancer in a phase I trials unit
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii692 (2018)

Development and implementation of national guidelines on lifestyle issues and cancer: Report from an ongoing quality improvement project
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii692 (2018)

Developing a patient reported experience measure (PREM) in secondary breast cancer (SBC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii692-viii693 (2018)

The Gastrointestinal and Lymphoma Unit lead nurse research role in Royal Marsden Hospital
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii694 (2018)

Cancer situation in Sub-Saharan countries: Development of educational, diagnosis and treatment plans
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii694 (2018)

Patients' learning and participation in their breast cancer care
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii695 (2018)

Specialized nursing interventions in optimizing patient communication undergoing total laryngectomy
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii695 (2018)

Safe navigation of CARs in a changing landscape
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii695-viii696 (2018)

Incidence and risk factors of phlebitis in patients with peripheral parenteral nutrition administration
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii695 (2018)

Overview of an acute oncology service in a UK cancer centre
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii696-viii697 (2018)

Peripherally inserted central venous catheters did not increase the risk of deep venous thrombosis in advanced colorectal cancer and lung cancer patients with bevacizumab
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii696 (2018)

Patients' interpretations and experiences of participation in cancer care
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii696 (2018)

Cancer nurse perspective on the emerging field of biosimilars in cancer care
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii696 (2018)

The development and evaluation of an online oncology portal
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii697 (2018)

Pilot study: Nurses' role in management of cutaneous toxicity in patients with targeted therapies anti EGFR-Is' treatment
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii697 (2018)

Rectal cancer survivorship: The struggle of the low anterior resection syndrome (LARS)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii698 (2018)

Nurse-led approaches to self-management of symptoms in routine Swiss outpatient care: A qualitative exploration
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii698 (2018)

Evaluation of a nursing aftercare intervention for patients with head and neck cancer treated with chemoradiation
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii698 (2018 )

Cancer pain knowledge and attitudes of nursing and medical professionals in a Greek general hospital
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii699 (2018)

Does individual genetic background predict acute radiation skin reactions in women undergoing adjuvant breast cancer radiotherapy?
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii699 (2018)

When symptom complexity is the norm: A mediation analysis between pain, anxiety, depression and fatigue
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii699 (2018)

Effect of aromatherapy massage on chemotherapy-induced peripheral neuropathic pain and fatigue in patients receiving oxaliplatin
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii699 (2018)

Trametinib synergizes with dexamethasone in KRAS-mutant myeloma cell lines through modulation of NDRG1 and induction of apoptosis
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii7 (2018)

Functional inhibition of TGF-β in colorectal cancer cells and its interaction with AXL receptor
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii7 (2018)

Isoform-specific AKT inhibition differentially affects cell functions in pancreatic adenocarcinoma
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii7 (2018)

Lymphocytes express receptor tyrosine kinases in patients with renal cell carcinoma and healthy donors
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii7-viii8 (2018)

Impact of hormone receptor status in HER2+ early breast cancer: A paradigm shift in the trastuzumab era
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii70 (2018)

Autoimmunity and benefit from trastuzumab treatment in breast cancer: Results from the HERA phase III trial
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii70 (2018)

Sefety profile of subcutaneous trastuzumab in patients with HER2-positive early breast cancer: The French HERMIONE non-interventional prospective study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii70-viii71 (2018)

App about chemotherapy: Helping the patient with cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii700 (2018)

Usability test for a CINV diary application for smartphones at oncology nursing
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii700-viii701 (2018)

The experience of dysgeusia in allogenic hematopoietic cell transplantation survivors: A qualitative study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii700 (2018)

"It may not affect you": Lived experiences and support needs of women who developed peripheral neuropathy following chemotherapy treatment for cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii700 (2018)

Medical makeup in cancer patients and its impact in their quality of life
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii701 (2018)

How to monitor outpatients undergoing active anticancer treatment? A feasibility study of the web-based tool "Onco'nect®"
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii701 (2018)

Perceived symptoms of Greek cancer patients during chemotherapy using the memorial symptom assessment scale
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii701 (2018)

Defining the lethal subclone in metastatic lung cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii702 (2018)

PERSEPHONE: 6 versus 12 months (m) of adjuvant trastuzumab in patients (pts) with HER2 positive (+) early breast cancer (EBC): Cost effectiveness analysis results
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii703 (2018)

Prognostic impact of anthracyclines and immune/proliferation markers in TNBC according to pCR after de-escalated neoadjuvant chemotherapy with 12 weeks of nab-paclitaxel/carboplatin or gemcitabine: Survival results of WSG-ADAPT-TN phase II trial
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii703 (2018)

The HOBOE-2 multicenter randomized phase III trial in premenopausal patients with hormone-receptor positive early breast cancer comparing triptorelin plus either tamoxifen or letrozole or letrozole + zoledronic acid
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii704 (2018)

Serum assessment of non-adherence to adjuvant endocrine therapy (ET) among premenopausal patients in the prospective multicenter CANTO cohort
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii704 (2018)

9 weeks versus 1 year adjuvant trastuzumab for HER2+ early breast cancer: Subgroup analysis of the ShortHER trial allows to identify patients for whom a shorter trastuzumab administration may have a favourable risk/benefit ratio
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii705 (2018)

Pregnancies after breast cancer: Is there a real need for fertility preservation? Results from the ARTEMIS cohort of 60 young patients
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii705 (2018)

Final analysis of the Male-GBG54 study: A prospective, randomised multi-centre phase II study evaluating endocrine treatment with either tamoxifen +/- gonadotropin releasing hormone analogue (GnRHa) or an aromatase inhibitor + GnRHa in male breast cancer patients
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii706 (2018)

IMpassion130: Results from a global, randomised, double-blind, phase III study of atezolizumab (atezo) + nab-paclitaxel (nab-P) vs placebo + nab-P in treatment-naive, locally advanced or metastatic triple-negative breast cancer (mTNBC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii707-viii708 (2018)

Overall survival (OS) with palbociclib plus fulvestrant in women with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC): Analyses from PALOMA-3
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii708 (2018)

Alpelisib (ALP) + fulvestrant (FUL) for advanced breast cancer (ABC): Results of the phase III SOLAR-1 trial
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii709 (2018)

Phase III trial of chidamide, a subtype-selective histone deacetylase (HDAC) inhibitor, in combination with exemestane in patients with hormone receptor-positive advanced breast cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii709 (2018)

Real-life data on the cardiac toxicity of adjuvant fixed-dose subcutaneous trastuzumab in HER2-positive breast cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii71 (2018)

Comprehensive evaluation of the pharmacokinetic profiles of SB3 and reference trastuzumab
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii71 (2018)

The impact of neoadjuvant dual HER2 targeting with pertuzumab and trastuzumab on pathological complete response (pCR) rates: Kent Oncology Centre (KOC) experience
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii71 (2018)

Ribociclib (RIBO) + letrozole (LET) in male patients (pts) with hormone receptor-positive (HR+), human epidermal growth factor receptor-2-negative (HER2-) advanced breast cancer (ABC) and no prior endocrine therapy (ET) for ABC: Preliminary subgroup results from the phase IIIb CompLEEment-1 trial
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii710 (2018)

Management and outcome of metastatic breast cancer in men in the national multicenter observational ESME program
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii710 (2018)

Breast cancer in Twitter: A real-world data exploratory study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii711 (2018)

Preliminary results of the first-in-human (FIH) study of MK-1454, an agonist of stimulator of interferon genes (STING), as monotherapy or in combination with pembrolizumab (pembro) in patients with advanced solid tumors or lymphomas
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii712 (2018)

Phase I/II, multicenter, open-label study of intratumoral/intralesional administration of the retinoic acid-inducible gene I (RIG-I) activator MK-4621 in patients with advanced or recurrent tumors
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii712 (2018)

Efficacy and safety of entrectinib in patients with NTRK fusion-positive (NTRK-fp) Tumors: Pooled analysis of STARTRK-2, STARTRK-1 and ALKA-372-001
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii713 (2018)

Inclusion of adolescents in adult early phase trials and young adults in paediatric early phase trials: A reality or a myth?
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii713 (2018)

Durable clinical benefit with nivolumab (NIVO) plus low-dose ipilimumab (IPI) as first-line therapy in microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii714 (2018)

Fluoropyrimidine (FP) + bevacizumab (BEV) + atezolizumab vs FP/BEV in BRAFwt metastatic colorectal cancer (mCRC): Findings from Cohort 2 of MODUL - a multicentre, randomized trial of biomarker-driven maintenance treatment following first-line induction therapy
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii714-viii715 (2018)

TRIBE2: A phase III, randomized strategy study by GONO in the 1st- and 2nd-line treatment of unresectable metastatic colorectal cancer (mCRC) patients (pts)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii715 (2018)

InterAACT: A multicentre open label randomised phase II advanced anal cancer trial of cisplatin (CDDP) plus 5-fluorouracil (5-FU) vs carboplatin (C) plus weekly paclitaxel (P) in patients (pts) with inoperable locally recurrent (ILR) or metastatic treatment naïve disease - An International Rare Cancers Initiative (IRCI) trial
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii715-viii716 (2018)

Negative hyper-selection of RAS wild-type (wt) metastatic colorectal cancer (mCRC) patients randomized to first-line FOLFOX plus panitumumab (Pan) followed by maintenance therapy with either 5FU/LV plus pan or single-agent pan: Translational analyses of the VALENTINO study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii716 (2018)

Eltanexor (KPT-8602), a second-generation selective inhibitor of nuclear export (SINE) compound, in patients with metastatic colorectal cancer (mCRC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii716 (2018)

A multi-omic analysis for prospective patient stratification in localised colorectal cancer (CRC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii717 (2018)

Profile of individuals who never undergo colorectal cancer screening
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii717 (2018)

TAGS: A phase III, randomised, double-blind study of trifluridine/tipiracil (TAS-102) versus placebo in patients with refractory metastatic gastric cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii718 (2018)

Updated safety and clinical activity results from a phase Ib study of atezolizumab + bevacizumab in hepatocellular carcinoma (HCC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii718-viii719 (2018)

A randomized multicentered phase II study to evaluate SHR-1210 (PD-1 antibody) in subjects with advanced hepatocellular carcinoma (HCC) who failed or intolerable to prior systemic treatment
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii719-viii720 (2018)

Neoadjuvant trial of nab-paclitaxel and atezolizumab (Atezo), a PD-L1 inhibitor, in patients (pts) with chemo-insensitive triple negative breast cancer (TNBC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii72 (2018)

A prediction model for pathological complete response after neoadjuvant chemotherapy of HER2-negative breast cancer patients
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii72 (2018)

Prognostic implications of circulating tumor cells (CTCs) after neoadjuvant chemotherapy for triple negative breast cancer (TNBC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii72 (2018)

Updated results from a phase II study of infigratinib (BGJ398), a selective pan-FGFR kinase inhibitor, in patients with previously treated advanced cholangiocarcinoma containing FGFR2 fusions
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii720 (2018)

CARRIE: A randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii720 (2018)

Influence of sex on chemotherapy efficacy and toxicity in oesophagogastric (OG) cancer: A pooled analysis of four randomised trials
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii721 (2018)

Radiotherapy (RT) to the primary tumour for men with newly-diagnosed metastatic prostate cancer (PCa): Survival results from STAMPEDE
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii722-viii723 (2018)

Effects of abiraterone acetate plus prednisone/prednisolone in high and low risk metastatic hormone sensitive prostate cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii722 (2018)

ERA 223: A phase III trial of radium-223 (Ra-223) in combination with abiraterone acetate and prednisone/prednisolone for the treatment of asymptomatic or mildly symptomatic chemotherapy-naïve patients (pts) with bone-predominant metastatic castration-resistant prostate cancer (mCRPC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii723 (2018)

JAVELIN renal 101: A randomized, phase III study of avelumab + axitinib vs sunitinib as first-line treatment of advanced renal cell carcinoma (aRCC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii724 (2018)

Molecular correlates differentiate response to atezolizumab (atezo) + bevacizumab (bev) vs sunitinib (sun): Results from a phase III study (IMmotion151) in untreated metastatic renal cell carcinoma (mRCC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii724-viii725 (2018)

Nivolumab (N) alone or in combination with ipilimumab (I) in patients (pts) with platinum-pretreated metastatic urothelial carcinoma (mUC), including the nivolumab 1mg/kg + ipilimumab 3mg/kg expansion from Check Mate 032
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii725 (2018)

A phase Ib/II study of neoadjuvant pembrolizumab (pembro) and chemotherapy for locally advanced urothelial cancer (UC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii726 (2018)

PD-L1 status and clinical outcomes to cabozantinib, sunitinib and everolimus in patients with metastatic clear-cell RCC treated on CABOSUN and METEOR clinical trials
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii726 (2018)

TROPHIMMUN, a 2 cohort phase II trial of the anti-PD-L1 monoclonal antibody avelumab in chemo-resistant gestational trophoblastic neoplasia (GTN) patients: Preliminary outcomes in cohort A
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii727-viii728 (2018)

Maintenance olaparib following platinum-based chemotherapy in newly diagnosed patients (pts) with advanced ovarian cancer (OC) and a BRCA1/2 mutation (BRCAm): Phase III SOLO1 trial
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii727 (2018)

Indicators of non-participation in cervical cancer screening: Results from the EDIFICE 6 survey
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii728 (2018)

Association of PD-L1 expression and gene expression profiling with clinical response to pembrolizumab in patients with advanced recurrent ovarian cancer: Results from the phase II KEYNOTE-100 study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii728 (2018)

KEYNOTE-048: Phase III study of first-line pembrolizumab (P) for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii729 (2018)

Cetuximab versus cisplatin in patients with HPV-positive, low risk oropharyngeal cancer, receiving radical radiotherapy
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii729-viii730 (2018)

Evaluation of the Mamma Typer® as a molecular predictor for pathological complete response (pCR) after neoadjuvant chemotherapy (NACT) and outcome in patients with different breast cancer (BC) subtypes
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii73 (2018)

Impact of clinical, morphologic and molecular characteristics on response to neoadjuvant systemic therapy (NAST) in metaplastic breast cancer (MpBC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii73-viii74 (2018)

Neoadjuvant ipilimumab plus nivolumab in early stage colon cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii731 (2018)

Safety and anti-tumor effects of MAGE-A10c796 TCR T-cells in two clinical trials
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii731 (2018)

Phase Ib KEYNOTE-200: A study of an intravenously delivered oncolytic virus, coxsackievirus A21 in combination with pembrolizumab in advanced NSCLC and bladder cancer patients
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii732 (2018)

Intratumoral BO-112, a double-stranded RNA (dsRNA), alone and in combination with systemic anti-PD-1 in solid tumors
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii732 (2018)

Tolerance and efficacy of immune-checkpoint inhibitors for cancer in people living with HIV (PWHIV)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii733 (2018)

OpACIN-neo: A multicenter phase II study to identify the optimal neo-adjuvant combination scheme of ipilimumab (IPI) and nivolumab (NIVO)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii734 (2018)

Updated relapse-free survival (RFS) and biomarker analysis in the COMBI-AD trial of adjuvant dabrafenib + trametinib (D + T) in patients (pts) with resected BRAF V600-mutant stage III melanoma
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii734-viii735 (2018)

Phase Ib/II, open label, multicenter, study of the combination of SD-101 and pembrolizumab in patients with advanced melanoma who are naïve to anti-PD-1 therapy
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii736 (2018)

Phase II study comparing pembrolizumab (PEM) with intermittent/short-term dual MAPK pathway inhibition plus PEM in patients harboring the BRAFV600 mutation (IMPemBra)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii736 (2018)

Initial results from a phase IIIb/IV study evaluating two dosing regimens of nivolumab (NIVO) in combination with ipilimumab (IPI) in patients with advanced melanoma (Check Mate 511)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii737 (2018)

CTONG 1103: Erlotinib versus gemcitabine plus cisplatin as neo-adjuvant treatment for stage IIIA-N2 EGFR-mutation non-small cell lung cancer (EMERGING): A randomised study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii738 (2018)

Neoadjuvant nivolumab (N) or nivolumab plus ipilimumab (NI) for resectable non-small cell lung cancer (NSCLC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii738 (2018)

Social and behavioral indicators of undergoing a screening test for lung cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii739 (2018)

Effects of physical exercise in non-operable lung cancer patients undergoing palliative treatment
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii739 (2018)

Impact of breast cancer subtype on survival after lumpectomy versus mastectomy for early stage invasive breast cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii74-viii75 (2018)

Immunomonitoring of triple negative breast cancer patients undergoing neoadjuvant therapy (GBG89, Geparnuevo trial)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii74 (2018)

Complete response (CR) to anthracycline-based chemotherapy using magnetic resonance imaging (MRI) predicts high rates of pathologic complete response (pCR) for triple negative breast cancer (TNBC) patients treated preoperatively with anthracycline and taxane-based regimens
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii74 (2018)

Evaluation of human epidermal growth factor receptor 2 overexpression (HER2+) after administration of neoadjuvant treatment (NAT) and prognostic impact in breast cancer (BC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii74 (2018)

Primary results of ALESIA: A randomised, phase III, open-label study of alectinib vs crizotinib in Asian patients with treatment-naïve ALK+ advanced NSCLC
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii740 (2018)

Mechanisms of acquired resistance to first-line osimertinib: Preliminary data from the phase III FLAURA study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii740 (2018)

Results of the GEOMETRY mono-1 phase II study for evaluation of the MET inhibitor capmatinib (INC280) in patients (pts) with METΔex14 mutated advanced non-small cell lung cancer (NSCLC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii741-viii742 (2018)

Analysis of resistance mechanisms to osimertinib in patients with EGFR T790M advanced NSCLC from the AURA3 study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii741 (2018)

IMpower130: Progression-free survival (PFS) and safety analysis from a randomised phase III study of carboplatin + nab-paclitaxel (CnP) with or without atezolizumab (atezo) as first-line (1L) therapy in advanced non-squamous NSCLC
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii742-viii743 (2018)

IMpower132: Efficacy of atezolizumab (atezo) + carboplatin (carbo)/cisplatin (cis) + pemetrexed (pem) as 1L treatment in key subgroups with stage IV non-squamous non-small cell lung cancer (NSCLC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii743-viii744 (2018)

Primary efficacy results from B-F1RST, a prospective phase II trial evaluating blood-based tumour mutational burden (bTMB) as a predictive biomarker for atezolizumab (atezo) in 1L non-small cell lung cancer (NSCLC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii744 (2018)

Maintenance chemotherapy versus follow-up after carboplatin and weekly paclitaxel doublet chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC): IFCT-1201 MODEL randomised phase III trial
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii744-viii745 (2018)

Overall survival results of ceritinib in ALKi-naïve patients with ALK-rearranged NSCLC (ASCEND-3)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii745 (2018)

Intracranial efficacy of brigatinib (BRG) vs crizotinib (CRZ) in the phase III ALTA-1L trial
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii746 (2018)

Uncommon EGFR mutations in lung adenocarcinomas: Clinical features and response to tyrosine kinase inhibitors
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii747-viii748 (2018)

Primary efficacy and updated safety of ceritinib (450mg or 600mg) with food vs 750mg fasted in ALK+ metastatic NSCLC (ASCEND-8)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii747 (2018)

Phase II results for single-agent nazartinib (EGF816) in adult patients (pts) with treatment-naive EGFR-mutant non-small cell lung cancer (NSCLC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii748 (2018)

Health-related quality of life (HRQoL) for pembrolizumab or placebo plus carboplatin and paclitaxel or nab-paclitaxel in patients with metastatic squamous NSCLC: Data from KEYNOTE-407
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii748-viii749 (2018)

Nab-paclitaxel + carboplatin induction followed by nab-paclitaxel maintenance in squamous non-small cell lung cancer (NSCLC): Results from the ABOUND.sqm study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii749-viii750 (2018)

Survival outcomes of dose dense neoadjuvant and adjuvant chemotherapy in triple-negative breast cancer patients: Indian scenario
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii75 (2018)

Index BRCA1/2 testing under a multidisciplinary program
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii75-viii76 (2018)

The accuracy of sentinel lymph node biopsy following neoadjuvant chemotherapy in clinically node positive breast cancer patients: A single institution experience
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii75 (2018)

Prognostic factors associated with pathological complete response in early breast cancer patients undergoing neoadjuvant chemotherapy: The importance of Ki-67 and molecular subtype
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii75 (2018)

IMpower131: Progression-free survival (PFS) and overall survival (OS) analysis of a randomised phase III study of atezolizumab + carboplatin + paclitaxel or nab-paclitaxel vs carboplatin + nab-paclitaxel in 1L advanced squamous NSCLC
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii750-viii751 (2018)

Financial toxicity in German cancer patients: How does a chronic disease impact the economic situation?
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii752 (2018)

Indicators of non-uptake of breast cancer screening: Results from the EDIFICE 6 survey
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii752 (2018)

Magnitude of clinical benefit of cancer drugs and time to health technology assessment (HTA) decisions in Europe
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii752 (2018)

Characterizing the risk of drug-drug interactions in sarcoma treated patients: Role of pharmacist integration
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii753-viii754 (2018)

A phase II/III trial of hafnium oxide nanoparticles activated by radiotherapy in the treatment of locally advance soft tissue sarcoma of the extremity and trunk wall
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii753 (2018)

Cabozantinib in patients with advanced osteosarcomas and Ewing sarcomas: A French Sarcoma Group (FSG)/ US National Cancer Institute phase II collaborative study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii753 (2018)

The use of complementary and alternative medicine (CAM) in sarcoma patients
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii754 (2018)

Final results of a phase II/III, randomized, double blind, placebo-controlled study to investigate the efficacy of a high potency multistrain probiotic, on chemotherapy induced diarrhea in cancer patients receiving fluropyrimidines and/or irinotecan-based therapy
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii755 (2018)

Physical activity (PA) and patterns of quality of life (QOL) after adjuvant chemotherapy (CT) for breast cancer (BC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii755 (2018)

Benefits of physical activity and sport integrated into the care pathway of oncology patient
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii755-viii756 (2018)

Identifying barriers to physical activity in patients with lung cancer: An Australian pilot study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii756 (2018)

Mutational landscape of metastatic cancers discovered from prospective clinical sequencing at community practice cancer program
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii757 (2018)

BRCA1/BRCA2 germline mutations and chemotherapy-related hematological toxicity in breast cancer patients
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii76 (2018)

PALB2 germ-line mutations in Russian breast cancer patients: Identification of recurrent alleles and analysis of phenotypic characteristics of the tumors
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii76 (2018)

Landscape of germline mutations in hereditary breast and ovarian cancer (HBOC) patients in Russia revealed by target panel sequencing
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii76 (2018)

Lynch syndrome-associated hereditary mutations cause breast and ovarian cancer: Results from Russian Heredetary Oncogenomics project
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii77 (2018)

Germline mutation status and therapy response in patients with triple-negative breast cancer (TNBC): Results of the Gepar Octo study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii77 (2018)

Impact of deleterious germline BRCA mutations, addition of taxanes and use of adjuvant endocrine therapy (ET) on anti-müllerian hormone (AMH) levels in early breast cancer (EBC) patients treated by adjuvant chemotherapy (CT)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii77 (2018)

Toxicity and clinical outcomes of partial breast irradiation (PBI) compared to whole breast irradiation (WBI) for early stage breast cancer: A systematic review and meta-analysis
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii78-viii79 (2018)

BRCA1/BRCA2 predictive genetic testing in an Irish population: A missed opportunity
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii78 (2018)

Incidence and survival among young women with stage I-III breast cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii78 (2018)

Risk of cardiovascular late effects in breast cancer survivors: A population-based study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii79 (2018)

Should anthracyclines always be present in the adjuvant treatment of breast cancer (BC)? A systematic review and meta-analysis of randomized controlled trials (RCTs)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii79 (2018)

Oncogenes analysis using GO-based clustering
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii8 (2018)

PNU-74654 enhances the antiproliferative effects of 5-FU in breast cancer and antagonizes thrombin induced cell growth via the Wnt pathway
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii8 (2018)

P21 has the potential to become the monitoring marker for the CDK4/6 inhibitors resistance in breast cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii8-viii9 (2018 )

PROMs following breast-conserving therapy for breast cancer: Results from a prospective longitudinal monocentric study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii80-viii81 (2018)

Diagnostic value of contrast enhanced digital mammography versus contrast enhanced MRI for preoperative evaluation of breast cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii80 (2018)

Relationship between androgen receptor and tumor-infiltrating lymphocytes in triple-negative breast cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii80 (2018)

Use of red clover in premenopausal breast cancer patients receiving hormonal adjuvant treatment: Biological and clinical implications from a randomized clinical trial
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii80 (2018)

Oncological outcome of fat grafting for breast reconstruction after cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii81 (2018)

Changes in body weight over 18-months follow-up among Chinese patients after breast cancer diagnosis
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii81-viii82 (2018)

Impact on disease-free survival (DFS) of the surgical waiting time (SWT) for patients (Pts) with early breast cancer (BC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii81 (2018)

Incidence of clinically significant toxicities in patients with high endoxifen concentrations
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii82 (2018)

Male breast cancer: Clinical and epidemiological patterns in the United States
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii82 (2018)

The aesthetic results after oncoplastic surgery in early breast cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii82 (2018)

Use of sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with cytology proven axillary node-positive breast cancer at diagnosis
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii83 (2018)

Omission of axillary lymph node dissection after positive sentinel lymph node: Validity and safety among early breast cancer patients treated with mastectomy
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii83 (2018)

The application of indocyanine green fluorescence navigation method to a sentinel lymph node biopsy after neoadjuvant chemotherapy in node-positive breast cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii83 (2018)

Pathologic response as a strong predictor of survival irrespective of phenotype in early breast cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii83-viii84 (2018)

Nomogram to predict non-sentinel lymph node status of breast cancer using total tumor load determined by one-step nucleic acid amplification (OSNA)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii84 (2018)

Voluntary deep inspiration breathhold (DIBH) experience in the radiotherapy for left sided breast cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii84 (2018)

Detecting bone density in early breast cancer survivors: The arm-DXA method
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii84 (2018)

A multicentre, international neoadjuvant, double-blind, randomized phase III trial comparing fulvestrant to a combination of fulvestrant and palbociclib (CDK 4/6 inhibitor) in patients with operable luminal breast cancer responding to fulvestrant (SAFIA study)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii85 (2018)

Psychological distress and health-related quality of life in women recently diagnosed with breast cancer in the Epi-GEICAM study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii85 (2018)

Multicenter study to evaluate the efficacy and standardize radiofrequency ablation therapy for early breast cancer (RAFAELO study)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii85-viii86 (2018)

Mutanome engineered RNA immuno-therapy (MERIT) for patients with triple negative breast cancer (TNBC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii86 (2018)

Preoperative pembrolizumab (Pembro) with radiation therapy (RT) in patients with operable triple-negative breast cancer (TNBC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii86 (2018)

Development of mPRO Mamma mobile application and its impact on the quality of life and health resource usage in patients with early stage and locally advanced breast cancer receiving chemotherapy
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii86 (2018)

CD8+, CD4+ and FOXP3+ cell profiles and their change after neoadjuvant chemotherapy in patients with triple negative breast cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii87 (2018)

Multiplex immunoassays analysis of plasma biomarker levels and response to neoadjuvant chemotherapy for locally advanced breast cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii87 (2018)

Expression of Sp17 and its association with clinicopathological parameters of breast cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii87-viii88 (2018)

Prognostic role of changes in neutrophil-to-lymphocyte ratio, tumor-infiltrating lymphocyte with programmed death ligand-1 in triple-negative breast cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii87 (2018)

Intratumoral heterogeneity on dedicated breast positron emission tomography before chemotherapy predicts the outcome of neoadjuvant chemotherapy in breast cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii88 (2018)

Results from NRG oncology/NSABP protocol DMP-1: Physician counseling
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii88 (2018)

Neoadjuvant eribulin plus carboplatin vs. paclitaxel plus carboplatin in patients with triple-negative breast cancer (TNBC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii88-viii89 (2018)

Real-world effectiveness of ribociclib + aromatase inhibitor, or endocrine monotherapy, or chemotherapy as first-line treatment in postmenopausal women with HR-positive, HER2-negative locally advanced or metastatic breast cancer: The RIBANNA study
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii89 (2018)

A phase Ib/II study of durvalumab combined with dose-dense EC in neoadjuvant setting for patients with locally advanced luminal B HER2(-) or triple negative breast cancers (B-IMMUNE)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii89 (2018)

Overexpression of NAMPT in adult T-cell leukemia/lymphoma patients and anti-tumor activity of a NAMPT inhibitor in vivo
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii9 (2018)

9-ING-41, a clinically relevant inhibitor of glycogen synthase kinase-3 (GSK-3), is active pre-clinically in human bladder and renal cell cancers
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii9 (2018)

A new natural compound identified through a metabolomic approach has cytotoxic activity against human colorectal cancer cell lines with acquired resistance to cetuximab
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii9 (2018)

Multiple myeloma metal levels and proteasome activity
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii9 (2018)

Primary results of the first nationwide molecular screening program in Spain for patients with advanced breast cancer (AGATA SOLTI-1301 study)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii90 (2018)

Patient-reported outcomes (PROs) in advanced breast cancer (ABC) treated with ribociclib + fulvestrant: Results from MONALEESA-3
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii90 (2018)

Ribociclib (RIB) + tamoxifen (TAM) or a non-steroidal aromatase inhibitor (NSAI) in premenopausal patients (pts) with hormone receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC): MONALEESA-7 patient-reported outcomes (PROs)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii91 (2018)

Balixafortide (a novel CXCR4 inhibitor) and eribulin in HER2-neg metastatic breast cancer (MBC) patients (pts): A phase I trial
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii91-viii92 (2018)

Patient-reported outcomes (PRO) in patients (pts) with advanced breast cancer and a germline BRCA1/2 mutation (gBRCAm) receiving talazoparib (TALA) vs physician's choice chemotherapy treatment (PCT): A focus on the EMBRACA triple negative (TNBC) subpopulation
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii91 (2018)

Post-treatment biopsies show evidence of cell cycle arrest and immune cell infiltration into tumors of ladiratuzumab vedotin-treated advanced breast cancer patients
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii92 (2018)

Oral paclitaxel and HM30181A demonstrate clinical activity in metastatic breast cancer (MBC) patients
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii92 (2018)

PERNETTA: A non-comparative randomized open label phase II trial of pertuzumab (P) + trastuzumab (T) with or without chemotherapy both followed by T-DM1 in case of progression, in patients with HER2-positive metastatic breast cancer (MBC): (SAKK 22/10 / UNICANCER UC-0140/1207)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii93 (2018)

Lucitanib for the treatment of HR+ HER2- metastatic breast cancer (MBC) patients (pts): Results from the multicohort phase II FINESSE trial
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii93 (2018)

Exploratory biomarker analysis in patients treated with vinorelbine plus everolimus or vinorelbine monotherapy as second-line treatment for HER2-negative advanced breast cancer: Final results from the randomized phase II trial VicTORia
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii94 (2018)

Applicability of the lung immune prognostic index (LIPI) to metastatic triple negative breast cancer (mTNBC) patients treated with immune checkpoint targeted monoclonal antibodies (ICT mAbs)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii94 (2018)

Peripheral blood mononuclear cell biomarkers predict response to immune checkpoint inhibitor therapy in metastatic breast cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii94 (2018)

Circulating exosomal microRNA profiling to depict mechanisms of chemotherapy resistance among triple negative breast cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii95 (2018)

The prevalence of PIK3CA mutations in HR+/HER2- metastatic breast cancer (BELLE2, BELLE3 and BOLERO2 clinical trials)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii95 (2018)

Analysis of the JAK2 gene in triple-negative breast cancer (TNBC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii95 (2018)

Differential molecular signature in patients from African origin with triple-negative breast cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii95 (2018)

EMBRACA: Comparison of efficacy and safety of talazoparib (TALA) and physician's choice of therapy (PCT) in patients (pts) with advanced breast cancer (aBC), a germline BRCA1/2 mutation (gBRCAm), and prior platinum treatment
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii96 (2018)

A risk score integrating lymphocytes ratios (LRs) and lactate dehydrogenase (LDH) levels to predict prognosis in metastatic breast cancer (MBC) patients
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii96 (2018)

EMBRACA: Efficacy and safety in comparing talazoparib (TALA) with physician's choice of therapy (PCT) in patients (pts) with advanced breast cancer (aBC) and a germline BRCA mutation (gBRCAm); BRCA1/BRCA2 subgroup analysis
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii96-viii97 (2018)

Exposure-safety analyses in breast cancer patients with germline BRCA1/2 mutations receiving talazoparib (TALA) in EMBRACA and ABRAZO trials
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii97 (2018)

Exposure-efficacy progression-free survival (PFS) analyses of breast cancer patients with germline BRCA1/2 mutations receiving talazoparib in the phase III EMBRACA trial
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii97 (2018)

An international systematic review (SR) of breast cancer (BC) BRCA mutation (BRCAm) prevalence
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii97-viii98 (2018)

Genetic screening, counselling, and treatment of BRCA mutation (BRCAm) carriers: A systematic review (SR) of international breast cancer (BC) guidelines
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii98 (2018)

Efficacy and toxicity of endocrine therapy + cyclin-dependent kinases 4/6 inhibitors (iCDK4/6) in metastatic breast cancer patients according to gBRCA status
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii98 (2018)

Clinical outcomes, treatment patterns and health resource utilization (HRU) among metastatic breast cancer (mbc) patients (pts) with germline BRCA mutation (gBRCAm)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii98-viii99 (2018)

Early results from an open-label phase 1b/II study of eribulin mesylate (EM) + pegvorhyaluronidase alfa (PEGHP20) combination for the treatment of patients with HER2-negative, high-hyaluronan (HA) metastatic breast cancer (MBC)
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii99 (2018)

Phase II clinical trial of first-line eribulin plus trastuzumab for advanced or recurrent HER2-positive breast cancer
, Annals of oncology: official journal of the European Society for Medical Oncology 29(Suppl): viii99 (2018)

The First Case of Glyphosate Resistance in Johnsongrass ( Sorghum halepense (L.) Pers.) in Europe
, Plants 9(3) (2020)

First Report of Aleurocanthus spiniferus on Ailanthus altissima : Profiling of the Insect Microbiome and MicroRNAs
, Insects 11(3) (2020)

Cell Penetrating Peptides, Novel Vectors for Gene Therapy
, Pharmaceutics 12(3) (2020)

Organic Mulch Increases Insect Herbivory by the Flea Beetle Species, Disonycha glabrata , on Amaranthus spp
, Insects 11(3) (2020)

Integrating Software Engineering Processes in the Development of Efficient Intrusion Detection Systems in Wireless Sensor Networks
, Sensors 20(5) (2020)

Cross-talk between Bcr-abl and the Thioredoxin System in Chronic Myeloid Leukaemia: Implications for CML Treatment
, Antioxidants 9(3) (2020)

Comparison of the Efficiency of BLUP and GBLUP in Genomic Prediction of Immune Traits in Chickens
, Animals: An Open Access Journal from Mdpi 10(3) (2020)

Investigating the Impact of Curing System on Structure-Property Relationship of Natural Rubber Modified with Brewery By-Product and Ground Tire Rubber
, Polymers 12(3) (2020)

Even Visually Intact Cell Walls in Waterlogged Archaeological Wood Are Chemically Deteriorated and Mechanically Fragile: A Case of a 170 Year-Old Shipwreck
, Molecules 25(5) (2020)

Inter-Organelle Membrane Contact Sites and Mitochondrial Quality Control during Aging: A Geroscience View
, Cells 9(3) (2020)

Three-Dimensional Model of Dorsal Root Ganglion Explant as a Method of Studying Neurotrophic Factors in Regenerative Medicine
, Biomedicines 8(3) (2020)

3,4-Dihydroxybenzalacetone (DBL) Prevents Aging-Induced Myocardial Changes in Senescence-Accelerated Mouse-Prone 8 (SAMP8) Mice
, Cells 9(3) (2020)

Multifaceted Aspects of Metabolic Plasticity in Human Cholangiocarcinoma: An Overview of Current Perspectives
, Cells 9(3) (2020)

Analysis of the Rolling Process of Alloy 6005 in a Three-High Skew Rolling Mill
, Materials 13(5) (2020)

Hypotensive Effect of Nanomicellar Formulation of Melatonin and Agomelatine in a Rat Model: Significance for Glaucoma Therapy
, Diagnostics 10(3) (2020)

Dysregulated Gut Homeostasis Observed Prior to the Accumulation of the Brain Amyloid-β in Tg2576 Mice
, International Journal of Molecular Sciences 21(5) (2020)

Video Laryngoscopic Intubation Using the King Vision TM Laryngoscope in a Simulated Cervical Spine Trauma: A Comparison Between Non-Channeled and Channeled Disposable Blades
, Diagnostics 10(3) (2020)

Direct Conjugation of Streptavidin to Encoded Hydrogel Microparticles for Multiplex Biomolecule Detection with Rapid Probe-Set Modification
, Polymers 12(3) (2020)

Finding an Effective Freezing Protocol for Turkey Semen: Benefits of Ficoll as Non-Permeant Cryoprotectant and 1:4 as Dilution Rate
, Animals: An Open Access Journal from Mdpi 10(3) (2020)

Integrated Analysis of miRNA-mRNA Network Reveals Different Regulatory Patterns in the Endometrium of Meishan and Duroc Sows during Mid-Late Gestation
, Animals: An Open Access Journal from Mdpi 10(3) (2020)

TonB-Dependent Transporters in Sphingomonads: Unraveling Their Distribution and Function in Environmental Adaptation
, Microorganisms 8(3) (2020)

Challenging a Myth and Misconception: Red-Light Vision in Rats
, Animals: An Open Access Journal from Mdpi 10(3) (2020)

Current Role of Total Laryngectomy in the Era of Organ Preservation
, Cancers 12(3) (2020)

Pan Aurora Kinase Inhibitor: A Promising Targeted-Therapy in Dedifferentiated Liposarcomas With Differential Efficiency Depending on Sarcoma Molecular Profile
, Cancers 12(3) (2020)

TSPAN8 as a Novel Emerging Therapeutic Target in Cancer for Monoclonal Antibody Therapy
, Biomolecules 10(3) (2020)

Combined Treatments of High Hydrostatic Pressure and CO 2 in Coho Salmon ( Oncorhynchus kisutch ): Effects on Enzyme Inactivation, Physicochemical Properties, and Microbial Shelf Life
, Foods 9(3) (2020)

Surface Probe Linker with Tandem Anti-Fouling Properties for Application in Biosensor Technology
, Biosensors 10(3) (2020)

Radiosensitization by Hyperthermia: The Effects of Temperature, Sequence, and Time Interval in Cervical Cell Lines
, Cancers 12(3) (2020)

Galectin-3 as a Next-Generation Biomarker for Detecting Early Stage of Various Diseases
, Biomolecules 10(3) (2020)

Effects of Black Quinoa Wet-Milling Coproducts on the Quality Properties of Bologna-Type Sausages During Cold Storage
, Foods 9(3) (2020)

Impact of the Monocarboxylate Transporter-1 (MCT1)-Mediated Cellular Import of Lactate on Stemness Properties of Human Pancreatic Adenocarcinoma Cells †
, Cancers 12(3) (2020)

Single Tracks as a Key Factor in Additive Manufacturing Technology-Analysis of Research Trends and Metal Deposition Behavior
, Materials 13(5) (2020)

Serine Biosynthesis Pathway Supports MYC-miR-494-EZH2 Feed-Forward Circuit Necessary to Maintain Metabolic and Epigenetic Reprogramming of Burkitt Lymphoma Cells
, Cancers 12(3) (2020)

Structure and Properties of High‑Strength Ti Grade 4 Prepared by Severe Plastic Deformation and Subsequent Heat Treatment
, Materials 13(5) (2020)

Investigation on Ultrasonic Welding Attributes of Novel Carbon/Elium ® Composites
, Materials 13(5) (2020)

IRE1α Promotes Zika Virus Infection via XBP1
, Viruses 12(3) (2020)

Immunotherapy in Multiple Myeloma
, Cells 9(3) (2020)

Acute Effects of Intermittent and Continuous Static Stretching on Hip Flexion Angle in Athletes with Varying Flexibility Training Background
, Sports 8(3) (2020)

Inactivation of Shiga Toxin-Producing Escherichia coli in Refrigerated and Frozen Meatballs Using High Pressure Processing
, Microorganisms 8(3) (2020)

Polyethylene Composites with Segregated Carbon Nanotubes Network: Low Frequency Plasmons and High Electromagnetic Interference Shielding Efficiency
, Materials 13(5) (2020)

Permeability and Antifouling Augmentation of a Hybrid PVDF-PEG Membrane Using Nano-Magnesium Oxide as a Powerful Mediator for POME Decolorization
, Polymers 12(3) (2020)

Developing Single Nucleotide Polymorphisms for Identification of Cod Products by RAD-Seq
, Animals: An Open Access Journal from Mdpi 10(3) (2020)

Thermodynamic and Spectroscopic Studies of the Complexes Formed in Tartaric Acid and Lanthanide(III) Ions Binary Systems
, Molecules 25(5) (2020)

Study of Microwave Heating Effect in the Behaviour of Graphene as Second Phase in Ceramic Composites
, Materials 13(5) (2020)

Melatonin's Antineoplastic Potential against Glioblastoma
, Cells 9(3) (2020)

Pre-Treatment and Post-Treatment Demodex Densities in Patients under Immunosuppressive Treatments
, Medicina 56(3) (2020)

Down Regulation and Loss of Auxin Response Factor 4 Function Using CRISPR/Cas9 Alters Plant Growth, Stomatal Function and Improves Tomato Tolerance to Salinity and Osmotic Stress
, Genes 11(3) (2020)

Targeting α-synuclein for PD Therapeutics: A Pursuit on All Fronts
, Biomolecules 10(3) (2020)

Nutrition in Liver Cirrhosis and Transplantation-Current State and Knowledge Gaps
, Nutrients 12(3) (2020)

Altered Plasma Acylcarnitines and Amino Acids Profile in Spinocerebellar Ataxia Type 7
, Biomolecules 10(3) (2020)

Citrus Auraptene Induces Expression of Brain-Derived Neurotrophic Factor in Neuro2a Cells
, Molecules 25(5) (2020)

Specific Substitutions in Region V2 of gp120 env confer SHIV Neutralisation Resistance
, Pathogens 9(3) (2020)

Associations among Bone Mineral Density, Physical Activity and Nutritional Intake in Middle-Aged Women with High Levels of Arterial Stiffness: A Pilot Study
, International journal of environmental research and public health 17(5) (2020)

Did the Number of Older People Requiring Long-Term Care and Expenditure Increase after the 2011 Great East Japan Earthquake? Analysis of Changes over Six Years
, International Journal of Environmental Research and Public Health 17(5) (2020)

Synthesis of Imidazole-Based Medicinal Molecules Utilizing the van Leusen Imidazole Synthesis
, Pharmaceuticals 13(3) (2020)

Development and Characterization of Hemicellulose-Based Films for Antibacterial Wound-Dressing Application
, Polymers 12(3) (2020)

Does the Association between Guardians' Sense of Coherence and their Children's Untreated Caries Differ According to Socioeconomic Status?
, International journal of environmental research and public health 17(5) (2020)

Experimental Research on Shear Failure Monitoring of Composite Rocks Using Piezoelectric Active Sensing Approach
, Sensors 20(5) (2020)

Fish By-Product Use as Biostimulants: An Overview of the Current State of the Art, Including Relevant Legislation and Regulations within the EU and USA
, Molecules 25(5) (2020)

Lightweight Concrete-From Basics to Innovations
, Materials 13(5) (2020)

Lipid Deposition and Metabolism in Local and Modern Pig Breeds: A Review
, Animals: An Open Access Journal from Mdpi 10(3) (2020)

Post-Processing of FDM 3D-Printed Polylactic Acid Parts by Laser Beam Cutting
, Polymers 12(3) (2020)

Successful High-Dosage Monotherapy of Tigecycline in a Multidrug-Resistant Klebsiella pneumoniae Pneumonia-Septicemia Model in Rats
, Antibiotics 9(3) (2020)

In Vitro Bioaccessibility of Ripe Table Olive Mineral Nutrients
, Foods 9(3) (2020)

Physicochemical and Digestion Properties of Potato Starch Were Modified by Complexing with Grape Seed Proanthocyanidins
, Molecules 25(5) (2020)

The B Subunit of PirAB vp Toxin Secreted from Vibrio parahaemolyticus Causing AHPND Is an Amino Sugar Specific Lectin
, Pathogens 9(3) (2020)

Oral Microbiota Profile Associates with Sugar Intake and Taste Preference Genes
, Nutrients 12(3) (2020)

Multi-Functional Potential of Presumptive Lactic Acid Bacteria Isolated from Chihuahua Cheese
, Foods 9(3) (2020)

Combining Immune Checkpoint Inhibitors with Anti-Angiogenic Agents
, Journal of Clinical Medicine 9(3) (2020)

A Population-Based Study of Healthcare Resource Utilization in Patients with Mitral Valve Prolapse
, International Journal of Environmental Research and Public Health 17(5) (2020)

Role of the TRPC1 Channel in Hippocampal Long-Term Depression and in Spatial Memory Extinction
, International Journal of Molecular Sciences 21(5) (2020)

Monoalkylated Epigallocatechin-3-gallate (C18-EGCG) as Novel Lipophilic EGCG Derivative: Characterization and Antioxidant Evaluation
, Antioxidants 9(3) (2020)

Oxidative Stress Biomarkers, Nut-Related Antioxidants, and Cardiovascular Disease
, Nutrients 12(3) (2020)

Explaining Intricate Morphometric Variability with Environmental Predictors: The Case of Globularia cordifolia Species Complex
, Plants 9(3) (2020)

Novel AIEgen-Functionalized Diselenide-Crosslinked Polymer Gels as Fluorescent Probes and Drug Release Carriers
, Polymers 12(3) (2020)

Astrocyte and Oligodendrocyte Cross-Talk in the Central Nervous System
, Cells 9(3) (2020)

Grain Orientation Optimization of Two-Dimensional Grain Selector during Directional Solidification of Ni-Based Superalloys
, Materials 13(5) (2020)

The Risk of Para-Aortic Lymph Node Metastases in Apparent Early Stage Ovarian Cancer
, Medicina 56(3) (2020)

Characteristics of the Two Asian Bumblebee Species Bombus friseanus and Bombus breviceps (Hymenoptera: Apidae)
, Insects 11(3) (2020)

Analytical Characterization and Sensory Analysis of Distillates of Different Varieties of Grapes Aged by an Accelerated Method
, Foods 9(3) (2020)

Proteomics-Based Detection of Immune Dysfunction in an Elite Adventure Athlete Trekking Across the Antarctica
, Proteomes 8(1) (2020)

Thermosensitive Hydrogel for Encapsulation and Controlled Release of Biocontrol Agents to Prevent Peanut Aflatoxin Contamination
, Polymers 12(3) (2020)

Designing Novel Therapies to Mend Broken Hearts: ATF6 and Cardiac Proteostasis
, Cells 9(3) (2020)

Preparation and Properties of Wood Tar-based Rejuvenated Asphalt
, Materials 13(5) (2020)

Measurement Methods Used to Assess the School Food Environment: A Systematic Review
, International Journal of Environmental Research and Public Health 17(5) (2020)

Food Industry Donations to Academic Programs: A Cross-Sectional Examination of the Extent of Publicly Available Data
, International Journal of Environmental Research and Public Health 17(5) (2020)

Growth under Fluctuating Light Reveals Large Trait Variation in a Panel of Arabidopsis Accessions
, Plants 9(3) (2020)

Characterization of Trehalose-6-phosphate Synthase and Trehalose-6-phosphate Phosphatase Genes and Analysis of its Differential Expression in Maize ( Zea mays ) Seedlings under Drought Stress
, Plants 9(3) (2020)

Control of Peri-Implant Mucous Inflammation by Using Chlorhexidine or Ultraviolet C Radiation for Cleaning Healing Abutments. Double-Blind Randomized Clinical Trial
, Materials 13(5) (2020)

The Hox Gene egl-5 Acts as a Terminal Selector for VD13 Development via Wnt Signaling
, Journal of Developmental Biology 8(1) (2020)

Good Vibrations: Structural Remodeling of Maturing Yeast Pre-40S Ribosomal Particles Followed by Cryo-Electron Microscopy
, Molecules 25(5) (2020)

The Theory of Planned Behaviour in Medical Tourism: International Comparison in the Young Consumer Segment
, International Journal of Environmental Research and Public Health 17(5) (2020)

The Use of a Non-Absorbable Membrane as an Occlusive Barrier for Alveolar Ridge Preservation: A One Year Follow-Up Prospective Cohort Study
, Antibiotics 9(3) (2020)

Abnormal Lysosomal Positioning and Small Extracellular Vesicle Secretion in Arterial Stiffening and Calcification of Mice Lacking Mucolipin 1 Gene
, International Journal of Molecular Sciences 21(5) (2020)

Properties Analysis of Asphalt Binders Containing Bayer Red Mud
, Materials 13(5) (2020)

Synthesis and Bioactivity Assessment of Novel Spiro Pyrazole-Oxindole Congeners Exhibiting Potent and Selective in vitro Anticancer Effects
, Molecules 25(5) (2020)

Middle Eastern Plant Extracts: An Alternative to Modern Medicine Problems
, Molecules 25(5) (2020)

Prediction of RC Bridge Member Resistance Decreasing in Time under Various Conditions in Slovakia
, Materials 13(5) (2020)

Facile Synthesis of Super-Microporous Titania-Alumina with Tailored Framework Properties
, Materials 13(5) (2020)

Stiffness Identification of Foamed Asphalt Mixtures with Cement, Evaluated in Laboratory and In Situ in Road Pavements
, Materials 13(5) (2020)

Circulating RNAs as Potential Biomarkers in Amyotrophic Lateral Sclerosis
, International Journal of Molecular Sciences 21(5) (2020)

Atomic Simulation of Nanoindentation on the Regular Wrinkled Graphene Sheet
, Materials 13(5) (2020 )

Characterization and Incidence of the First Member of the Genus Mitovirus Identified in the Phytopathogenic Species Fusarium oxysporum
, Viruses 12(3) (2020)

A Rapid and High Throughput MIC Determination Method to Screen Uranium Resistant Microorganisms
, Methods and Protocols 3(1) (2020)

Engineered Recombinant Single Chain Variable Fragment of Monoclonal Antibody Provides Protection to Chickens Infected with H9N2 Avian Influenza
, Vaccines 8(1) (2020)

Experimental and Numerical Assessment of Fibre Bridging Toughening Effects on the Compressive Behaviour of Delaminated Composite Plates
, Polymers 12(3) (2020)

Spinel rGO Wrapped CoV 2 O 4 Nanocomposite as a Novel Anode Material for Sodium-Ion Batteries
, Polymers 12(3) (2020)

Exposure Assessment of Indoor PM Levels During Extreme Dust Episodes
, International Journal of Environmental Research and Public Health 17(5) (2020)

GABAergic Input Affects Intracellular Calcium Levels in Developing Granule Cells of Adult Rat Hippocampus
, International Journal of Molecular Sciences 21(5) (2020)

Assessment of Antioxidants in Selected Plant Rootstocks
, Antioxidants 9(3) (2020)

Additional Value of Machine-Learning Computed Tomographic Angiography-Based Fractional Flow Reserve Compared to Standard Computed Tomographic Angiography
, Journal of Clinical Medicine 9(3) (2020)

W-GUN: Whale Optimization for Energy and Delay-Centric Green Underwater Networks
, Sensors 20(5) (2020 )

Judging Relative Onsets and Offsets of Audiovisual Events
, Vision 4(1) (2020)

Strain-Dependent Activity of Zika Virus and Exposure History in Serological Diagnostics
, Tropical Medicine and Infectious Disease 5(1) (2020)

Facilitators and Barriers Associated with Uptake of HIV Self-Testing among Men Who Have Sex with Men in Chongqing, China: A Cross-Sectional Survey
, International Journal of Environmental Research and Public Health 17(5) (2020)

Interplay between Endoplasmic Reticulum (ER) Stress and Autophagy Induces Mutant p53H273 Degradation
, Biomolecules 10(3) (2020)

Homocysteine Induces Inflammation in Retina and Brain
, Biomolecules 10(3) (2020)

Potential Factors Influencing Repeated SARS Outbreaks in China
, International Journal of Environmental Research and Public Health 17(5) (2020)

Multiplex Recombinase Polymerase Amplification Assay for the Simultaneous Detection of Three Foodborne Pathogens in Seafood
, Foods 9(3) (2020)

Verification of the Field Productivity of Rehmannia glutinosa (Gaertn.) DC. Developed Through Optimized In Vitro Culture Method
, Plants 9(3) (2020)

In Vitro Regeneration Potential of White Lupin (Lupinus albus ) from Cotyledonary Nodes
, Plants 9(3) (2020)

Effect of Concentration of Thermochromic Ink on Performance of Waterborne Finish Films for the Surface of Cunninghamia Lanceolata
, Polymers 12(3) (2020)

A Self-Powered Flexible Thermoelectric Sensor and Its Application on the Basis of the Hollow PEDOT:PSS Fiber
, Polymers 12(3) (2020)

A Sensitive, Point-of-Care Detection of Small Molecules Based on a Portable Barometer: Aflatoxins In Agricultural Products
, Toxins 12(3) (2020)

The Growing Interest in Development of Innovative Optical Aptasensors for the Detection of Antimicrobial Residues in Food Products
, Biosensors 10(3) (2020)

Enhanced Surface Properties of Carbon Fiber Reinforced Plastic by Epoxy Modified Primer with Plasma for Automotive Applications
, Polymers 12(3) (2020)

Evaluation of Volatile Compounds in Milks Fermented Using Traditional Starter Cultures and Probiotics Based on Odor Activity Value and Chemometric Techniques
, Molecules 25(5) (2020)

Hypervolemia-Induced Immune Disturbances Do Not Involve IL-1ß but IL-6 and IL-10 Activation in Haemodialysis Patients
, Toxins 12(3) (2020)

Regulation of Small GTPase Rab20 by Ikaros in B-Cell Acute Lymphoblastic Leukemia
, International journal of molecular sciences 21(5) (2020)

Influence of Polymer Charge on the Localization and Dark- and Photo-Induced Toxicity of a Potential Type I Photosensitizer in Cancer Cell Models
, Molecules 25(5) (2020)

Changes in Intestinal Microbiota and Predicted Metabolic Pathways During Colonic Fermentation of Mango ( Mangifera indica L.)-Based Bar Indigestible Fraction
, Nutrients 12(3) (2020)

Methionine Restriction and Cancer Biology
, Nutrients 12(3) (2020)

Standard Versus Ultrasound-Guided Cannulation of the Femoral Artery in Patients Undergoing Invasive Procedures: A Meta-Analysis of Randomized Controlled Trials
, Journal of Clinical Medicine 9(3) (2020)

Artificial Intelligence in Acute Kidney Injury Risk Prediction
, Journal of Clinical Medicine 9(3) (2020)

Rapid Loss of Tidal Flats in the Yangtze River Delta since 1974
, International Journal of Environmental Research and Public Health 17(5) (2020)

Early Aspirin Discontinuation Following Acute Coronary Syndrome or Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
, Journal of Clinical Medicine 9(3) (2020)

Molecular Genetics of Niemann-Pick Type C Disease in Italy: An Update on 105 Patients and Description of 18 NPC1 Novel Variants
, Journal of Clinical Medicine 9(3) (2020)

Sleep in the Natural Environment: A Pilot Study
, Sensors 20(5) (2020)

Evaluation of Seven Different RNA-Seq Alignment Tools Based on Experimental Data from the Model Plant Arabidopsis thaliana
, International Journal of Molecular Sciences 21(5) (2020)

Data Analytics and Applications of the Wearable Sensors in Healthcare: An Overview
, Sensors 20(5) (2020)

Deciphering the Biological Activities of Dunaliella sp. Aqueous Extract from Stressed Conditions on Breast Cancer: from in Vitro to in Vivo Investigations
, International Journal of Molecular Sciences 21(5) (2020)

Regular Black Bean Consumption Is Necessary to Sustain Improvements in Small-Artery Vascular Compliance in the Spontaneously Hypertensive Rat
, Nutrients 12(3) (2020)

Experimental and Theoretical Study of Multifrequency Surface Acoustic Wave Devices in a Single Si/SiO 2 /ZnO Piezoelectric Structure
, Sensors 20(5) (2020)

Using the SITAR Method to Estimate Age at Peak Height Velocity of Children in Rural South Africa: Ellisras Longitudinal Study
, Children 7(3) (2020)

WiFi-Based Driver's Activity Monitoring with Efficient Computation of Radio-Image Features
, Sensors 20(5) (2020)

Phylogenetic Analysis of Belgian Small Ruminant Lentiviruses Supports Cross Species Virus Transmission and Identifies New Subtype B5 Strains
, Pathogens 9(3) (2020)

Finding Characteristics of Users in Sensory Information: From Activities to Personality Traits
, Sensors 20(5) (2020)

Simultaneous and Efficient Production of Furfural and Subsequent Glucose in MTHF/H 2 O Biphasic System via Parameter Regulation
, Polymers 12(3) (2020)

Prevention of Encrustation on Ureteral Stents: Which Surface Parameters Provide Guidance for the Development of Novel Stent Materials?
, Polymers 12(3) (2020)

Co-Administration of the Traditional Medicines Hachimi-Jio-Gan and Hochu-Ekki-To Can Reverse Busulfan-Induced Aspermatogenesis
, International Journal of Molecular Sciences 21(5) (2020)

Rosa davurica Pall. Improves Propionibacterium acnes -Induced Inflammatory Responses in Mouse Ear Edema Model and Suppresses Pro-Inflammatory Chemokine Production via MAPK and NF-κB Pathways in HaCaT Cells
, International Journal of Molecular Sciences 21(5) (2020)

Expression of Interleukin-6 and the Interleukin-6 Receptor Predicts the Clinical Outcomes of Patients with Soft Tissue Sarcomas
, Cancers 12(3) (2020)

Construction of BPQDs/Ti 3 C 2 @TiO 2 Composites with Favorable Charge Transfer Channels for Enhanced Photocatalytic Activity under Visible Light Irradiation
, Nanomaterials 10(3) (2020)

Recent Advances in Indoor Localization via Visible Lights: A Survey
, Sensors 20(5) (2020)

Growth under Fluctuating Light Reveals Large Trait Variation in a Panel of Arabidopsis Accessions
, Plants 9(3) (2020)

Breast Density Notification: An Australian Perspective
, Journal of Clinical Medicine 9(3) (2020)

Influence of Bone Marrow-Derived Mesenchymal Stem Cell Therapy on Oxidative Stress Intensity in Minimally Conscious State Patients
, Journal of Clinical Medicine 9(3) (2020)

MSC Based Therapies-New Perspectives for the Injured Lung
, Journal of Clinical Medicine 9(3) (2020)

Design and Calibration of an Instrumented Seat Post to Measure Sitting Loads while Cycling
, Sensors 20(5) (2020)